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Abstract 
i 
 
Health and emotional benefits are linked to participation in exercise, however 
single-impact load (e.g. trauma) and altered joint loading can cause bone 
fracture(s) resulting in permanent cartilage damage and increased risk of 
osteoarthritis (OA).  
 
This study investigated the role of single mechanical load and the effects of 
chondroprotective agents over short periods of time (2-30 min) post impact. 
Mechanical load (force 1.14 N) induced by a drop tower device caused cell 
death from as early as 2 min. Pre-incubation in hypertonic media protected 
chondrocytes from cell death, whereby at 30 min, death was decreased from 
9.22 % to 3.42 % (p<0.01), thus implicating volume regulatory changes as a 
potential key mechanism for chondroprotection, with in situ chondrocytes 
altering their cell volume in response to hypertonicity by 20 %. Investigation 
of the cell cytoskeleton, showed that hypertonicity increased cortical actin by 
29 % within the superficial zone (SZ) only (p<0.01).  
 
Volume and actin polymerisation regulation are governed by intracellular 
Ca2+ and the regulatory volume decrease (RVD) inhibitor REV5901 has been 
linked to both and was therefore tested for its potential chondroprotective 
properties. Impact led to cell death, which was significantly reduced by 
REV5901 from 10.92 % to 5.44 % (p<0.001) and initial cell volume was 
reduced by 25%. Cortical actin staining was increased by 20 % within the SZ 
of articular cartilage only (p<0.01). GdCl3 (blocker for stretch-activated 
calcium channels), uridine-5’-triphosphate (uridine; calcium mobilizing 
mediator) and the phosphoinositide 3-kinases (PI3K) inhibitor wortmannin 
were used to determine its mechanism of action. Wortmannin alone 
increased cell death and inhibited REV5901 chondroprotective effects with 
no alteration in cell volume compared to REV5901 alone. Whilst uridine 
reduced cell volume with 20 % (p<0.05) it did not reduce cell death 
significantly from 10.92 % to 8.10 % (p>0.05) compared to control. GdCl3 
inhibited REV5901 chondroprotective effects by increasing cell death by ~ 5 
% compared to control (p<0.05), F-actin staining appeared reduced 72.84 AU 
and not significantly different from control (p>0.05). 
 
The role of the cell cytoskeleton is important for cell mechanotransduction 
and for maintaining integrity as actin microfilaments are recognized to bear 
tension therefore, alterations of the actin-binding proteins responsible for 
actin treadmilling cofilin, profilin and gelsolin mRNA was compared to 
untreated chondrocytes. REV5901 was observed to reduce cofilin (known 
actin depolymerizing factor) with 30 % (p<0.05) and increase profilin 
significantly by 75 % (p<0.001) respectively. Western blot analysis showed 
that only cofilin and gelsolin were expressed in all samples with no detection 
of profilin. REV5901 was observed to significantly reduce cofilin by 28 % 
(p<0.05). 
 
This data highlights that REV5901 exhibits chondroprotective properties in 
part due to the polymerisation of the actin cytoskeleton via PI3Ks pathway. 
This could offer a novel therapeutic opportunity for perention of irreversible 
cartilagedamage following acute impact trauma. 
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Numerous and essential health and emotional benefits are linked to the 
participation in exercise (Bauman, 2004, Buckwalter and Martin, 2004, 
Peluso et al., 2005, Wang et al., 2011, Hamer et al., 2012) but in high-
impact, load-bearing sports (e.g. football, tennis, running, boxing) 
mechanically elicited cartilage trauma is a major concern as many of them 
are linked to trauma and concomitant risk of joint failure in later life (Saxon et 
al., 1999, Lequesene, 2004, Ross, 2005). Indeed, whilst retrospective cohort 
studies support the conclusion that moderate exercise does not increase the 
predisposition to osteoarthritis (OA), there is evidence that high impact sport 
increases the risk of OA (Spector et al., 1996, Urquhart et al., 2007). Sports 
injury that cause joint instability or cartilage trauma is a major concern in 
high-impact, load-bearing sport and directly linked to the onset of post 
traumatic OA (Saxon et al., 1999, Lotz and Kraus, 2010, Stehling et al., 
2012). Therefore, the elucidation of cartilage damage as a consequence of 
mechanical trauma is of paramount importance for both the casual, 
professional and elite sports person. 
1.1 Cartilage and Chondrocyte 
1.1.1 Cartilage and its structure  
 
Articular cartilage is semi-opaque, grey or white, dense and highly 
specialised connective tissue capable of withstanding considerable pressure 
and can be found on the opposing surface of the synovial joints (Stockwell, 
1991, Buckwalter, 2002). Lacking both a blood and nervous supply it is an 
avascular, aneuronal and alymphatic tissue (Wilkins et al., 2000, Goldring et 
al., 2011) and in conjunction with synovial fluid, it provides a smooth, low 
friction surface suitable for joint articulation therefore protecting the 
underlying bone from shearing forces generated by load (Matthews et al., 
1986, Darling et al., 2006). Three types of cartilage exist: fibro, hyaline and 
elastic cartilage whereby hyaline (also called articular cartilage), is the type of 
cartilage that lines the articulating surfaces of long bones in diarthrodial joints 
(Ratcliffe and Mow, 1996, Nordin and Frankel, 2001). Thin cartilage is found 
in congruent joints such as the ankle, whereas thicker cartilage is found in 
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incongruent joints such as the knee (Muir et al., 1970, Henden and Beeson, 
2009). 
 
Articular cartilage is comprised of an extracellular matrix (ECM) synthesised 
by the chondrocytes which represent ~5 % of the tissue volume (Stockwell, 
1987). Chondrocytes are the sole resident cell type in articular cartilage 
(Stockwell, 1979, Goldring and Goldring, 2007) and thus play a crucial role in 
the organisation, maintenance, synthesis and turnover of extracellular matrix 
(ECM) (Chahine et al., 2013). Chondrocytes produce and maintain the ECM 
in response to the changing environmental pressures that is modulated by 
joint loading with enhanced loading stimulating matrix synthesis (Urban, 
1994, Wilkins, 2003, Goldring et al., 2011) and in return they are protected 
from potential damaging forces of mechanical loads by the very same ECM 
they produce (Howell, 1986, Hall, 1998, Guilak et al., 2001, Goldring 2012b). 
  
The ECM is a macromolecular construction that plays an extensive role in 
variety of different functions and is comprised of a cross network consisting 
of collagen fibrils and proteoglycans (PGs), specifically hyaluronan and the 
highly negatively charged molecule aggrecan. In addition, there are a small 
number of non-collagenous glycoproteins that contribute to tissue regulation 
(Durr et al., 1996, Poole, 1997). Collagen is a major protein of ECM and 
there are various different types of collagens: type I, II, III, VI, X, or XI, 
however, Collagen II (col2) is the most abundant primary collagen of articular 
cartilage, comprising of 80-90 % of the total collagen content in healthy adult 
articular tissue (Bacerra et al., 2010), forming a dense fibrous network which 
is responsible for supporting the cells against shear stress (Guilak, 1995, 
Muir, 1995, Eyre et al., 2006, Goldring and Goldring, 2007, Goldring and 
Macu, 2009). It forms heteropolymer complexes with other cartilage 
collagens such as collagen IX and XI (Goldring, 2012b). Collagen Type VI is 
present in different cartilage types and it has a distinctive filamentous 
network that is concentrated around the chondrocyte and therefore this 
protein is a hallmark for chondrons microanatomy (Figure 1.1), whilst 
collagen X is restricted to transition areas such as the calcified zone and is 
distinguished by its short non-fibril-forming structure that surrounds cells as 
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in a hypertrophic zone (Poole, 1997, Nordin and Frankel, 2001, Eyre et al., 
2006, Goldring, 2012b). 
 
Proteoglycans (PGs) are negatively charged molecules that comprise of long 
repeated linear chains of specific disaccharides called glycosaminoglycans 
(GAG) attached to a core protein. Aggrecan, one of the most common and 
predominant PG in cartilage (Milner, Willkins and Gibson, 2012) binds 
Hyaluronic acid (HA) and GAG short side chains: chondroitin sulphate (CS) 
and keraftan sulphate (KS) (Goldring, 2012b). PGs are responsible for 
providing articular cartilage with the ability to resist tension (Urban, 1994), 
and due to their negative change they attract water and cations becoming 
hydrated, resulting in an expansion of up to five times their original size 
(Stockwell, 1991, Wilkins et al., 2000). This causes the PG to swell and 
become trapped in the collagen meshwork during joint loading, during this 
process hydrostatic pressure is raised and ECM deforms. When load is 
removed, PGs re-embed water and achieve a new equilibrium, thus allowing 
cartilage to maintain a steady state (Hall et al., 1996). The ‘trapped’ nature of 
the PGs within the dense collagen network shapes an extraordinary ionic 
environment that has an uneven distribution of charged ions as a result of 
impermeable or immobilised charged molecules and is described by the 
Gibbs-Donnan equilibrium (Maroudas, 1979).  
 
Articular cartilage also incorporates several other proteins responsible for the 
regulation and turnover of the ECM, anchorin and fibronectin (Goldring and 
Macu, 2009). Fibronectin, is a dimeric glycoprotein that regulates cell 
adhesion and differentiation (Glant et al., 1985), whiles anchrorin is a 
collagen binding protein (Hofmann et al., 1992). 
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Figure 1.1 Components in the cartilage extracellular matrix. 
  
Molecular organisation of territorial and interritorial matrix (Diagram is not drawn to scale). 
Illustration of cartilage ECM presenting the different molecular organization of close to cell 
(territorial) and distant from cell (interritorial) space. Within the territorial area major 
constituents are collagen II and VI and proteoglycans (aggrecan, hyaluronic acid (HA), 
keraftan sulphate (KS) and chondroitin sulphate (CS)). CD44 is a cell surface receptor for 
HA. 
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1.1.2 The Chondrocyte 
 
This terminally differentiated cell (Goldring, 2000) is the unique cell type 
within articular cartilage and in the human femoral head, they reside at a 
density of ~10,000 chondrocytes/µm3 (Stockwell, 1979, Goldring, 2012a). 
Chondrocytes operate at low oxygen levels and are entirely reliant on 
nutrients being provided by diffusion from the articular surface due to the 
avascular nature of the tissue.  
 
Articular cartilage is arranged into four distinct zones, superficial/tangential 
zone (SZ) situated at the top of the cartilage layer, followed by the mid zone 
(MZ), characterized with the highest content of GAG, deep/radial zone (DZ), 
and the calcified zone (Stockwell, 1991, Figure 1.2). The protective 
properties of the cartilage are a consequence of the distinct zones and each 
zone is characterised by the content of collagen, PGs and the shape/size of 
chondrocytes within it. Organization of collagen within the SZ represents 10-
20 % of the cartilage thickness (Kim et al., 1994) and consists mainly of 
collagen type II, which is oriented in parallel to the articular surface (Weiss et 
al., 1968). Chondrocytes within this zone are elongated and situated in the 
shear stress plane of the articular surface at an approximate volume 454 ± 
18 µm3 (Urban, 1994, Bush and Hall, 2003). Conversely, within the MZ, 
collagen fibrils are randomly situated in pairs, and the chondrocytes appear 
round in shape and often arranged in pairs. MZ represents about 40-60 % of 
cartilage thickness and is often referred to as transitional to the DZ, with a 
cell volume estimated 553 ± 15 µm3 (Urban, 1994, Bush and Hall, 2003). 
Within the DZ ellipsoidal shaped chondrocytes are arranged in groups 
(stacks) where cells are situated in the middle with collagen fibres distributed 
between radially oriented collagen fibres. This crosses the tidemark and 
fastens the cartilage to the bone at the calcified zone, this distinct tidemark is 
considered as a boundary between DZ and the bone, thus separating the 
non-calcified tissue from the calcified tissue, with a volume of 805 ± 79 µm3 
(Guilak, 1995, Bush and Hall, 2003, Athanasiou et al. 2004, Darling et al., 
2004).  
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Figure 1.2 Representative Distribution of zones into cartilage.  
 
Full depth bovine articular cartilage explants were removed aseptically from metacarpal 
phalangeal joint and incubated with calcein-AM (green) and propidium iodide (red). Image 
was acquired by confocal laser scanning technique and clearly shows the three distinctive 
zones and the calcified zone. SZ cells are elongated and aligned in parallel, MZ cells are 
rounded and situated in pairs and DZ chondrocytes in clusters of elongated cells. At the very 
end, is situated the calcified zone separated from the other three zones by a tidemark. 
Image shows the coronal CLSM projection of cartilage, acquired by Dr P. G. Bush, adapted 
with permission. 
  
Tide Mark 
Mid Zone 
Deep Zone 
Superficial Zone  
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1.2 Cytoskeletal Organisation  
 
The mechanical response of the cell to loading is dependant on mechanical 
properties, cell morphology and ECM interactions all of which are influenced 
by the cytoskeleton (Chahine et al., 2013). The cytoskeleton comprises of a 
dynamic 3D network including actin microfilaments, tubulin microfilaments 
and vimentin intermediate filaments (Benjamin et al., 1994, Henson and 
Vincent, 2008, Blain, 2009). The organization of these cytoskeletal networks 
have been described in full-depth explants, isolated primary cells and 
monolyer (Durrant et al., 1999, Trickery et al., 2004, Sasazki et al., 2008). 
Within bovine articular cartilage, F-actin is distributed uniformly throughout 
the tissue depth, conversely to both vimentin and tubulin, which are 
predominantly detected within the SZ compared to DZ chondrocytes 
(Langelier et al., 2000). In monolayer culture, chondrocytes have an ameboid 
shape and their diameter is greater than both in situ and 3D cultured 
chondrocytes, whilst the cytoskeleton is predominately located just beneath 
the cell membrane (Sasazki et al., 2008).  
 
Tubulin microtubules have the ability to self assemble from the polymeric 
microtubular structure and exist as dimeric proteins with an α and β structure, 
where by each monomer has a molecular mass of 55 kDa (Valiron et al., 
2009). Within chondrocytes there is a loose distribution of these proteins and 
they are not thought to be essential for cell integrity (Langelier et al., 2000, 
Trickery et al., 2004), whilst mechanical loading has been shown to have no 
effect on tubulin concentration and distribution.  
 
Vimentin intermediate filament networks within chondrocytes are highly 
dynamic in nature, whereby all filaments have similar structural features. 
These highly organised proteins spread within the cytoplasm and connect the 
nucleus with the cell periphery (Trickery et al., 2004). By examining the 
cytoskeletal architecture of chondrocytes in 3D cultures, it was recently 
reported that vimentin filaments represent a less dynamic and more rigid 
structure relative to the actin filaments (Steklov et al., 2009, Haudenschild, 
2011). Vimentin filaments are the most prominent filament within weight 
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bearing regions and static load increases their organisation (Eggli et al., 
1988, Henson and Vincent, 2008). In conjunction with actin filaments, the 
vimentin network plays a crucial role in the chondrocytes integrity and 
mechanotransduction abilities (Trickery et al., 2004, Blein et al., 2006, 
Henson and Vincent, 2008, Steklov et al., 2009).  
 
Actin, a globular protein (termed G-actin) of 43 kDa consists of three different 
monomers (α, β and γ; Blain, 2009) and has been reported to be the most 
abundant protein in eukaryotic cells (Disanza et al., 2005). Under 
physiological conditions G-actin forms highly organised polymer filaments 
called filamentous actin (F-actin; Figure 1.3). This is formed by 
polymerisation of G-actin that has been shown to be Mg2+/Ca2+ and ATP 
dependant. This ATP-dependant process of actin filament formation is 
reversible, and when ADP-actin monomers undergo nucleotide exchange 
producing ATP–actin they undergo a new round of polymerisation in a 
process of assembly and disassembly termed ‘treadmilling’ (Pollared and 
Borisy, 2003). The ‘treadmilling’ of actin filaments is regulated by variety of 
actin binding proteins that promote nucleation of actin such as profilin and 
Arp2/3 complex (Goley and Welch, 2006), or filament depolymerisation such 
as actin-depolymerising factor (ADF) and cofilin (Ono, 2007, Bamburg and 
Bernstein, 2010), and those that cap the filament ends such as gelsolin 
(Cooper and Schafer 2000, Erickson et al., 2003).  
 
The organisation of F-actin has been implicated to be involved in cartilage 
chondrocyte mechanics and mechanotransduction  (Guilak 1995, Grodzinsky 
et al., 2000, Erickson et al., 2003, Darling et al., 2006, Campbell et al., 2007) 
and is influenced by mechanical loading, osmotic environment and 
inflammation, all of which are associated with OA (Table 1.1; Li et al., 2007). 
Manipulation of external osmotic pressure results in remodelling of the actin 
cytoskeleton, whereby hypo-osmotic stress leads to F-actin depolymerisation 
and reorganisation (Chao et al., 2006, Blain, 2009). Mechanical pressure can 
alter F-actin in a load dependent fashion (Knight et al., 2006) whereby 
increasing pressure to 15 MPa leads to a decrease in F-actin which 
INTRODUCTION! 10 
 
  
 
completely depolymerises when the pressure increases to 30 MPa 
(Parkkinen et al., 1995). However, actin-binding proteins such as ADF and 
cofilin are significantly increased after mechanical stimulation of 
chondrocytes and occurred together with temporal disassembly of F-actin 
(Campbell et al., 2007).  
 
 
 
 
 
 
Table 1.1 Organisation of the F-actin in healthy, osteoarthritic and stressed articular 
chondrocytes. 
 
The organisation of F-actin in healthy chondrocytes has been described to be cortically and 
peripherally localised. Mechanical loading alters actin in a load dependent fashion where by 
manipulation of external osmotic pressure results in remodelling of the actin cytoskeleton. 
Distinguishing criteria are characterised here. (Adapted from Blain, 2009). 
 
 
 
 
 
 
 
 
Chondrocyte 
F-actin organisation  
Characteristics 
Reference  
Healthy  Cortical distribution  
Blain et al., 2006, 
Sasazki et al., 2008   
 
Mechanical 
Loading 
 
Load dependent, reversible 
loss of actin fibres 
 
Blain et al., 2006, 
Campbell et al., 
2007, Knight et al., 
2006, Parkkinen et 
al., 1995, Trickery et 
al., 2004, 
Osmotic 
Stress 
Hypo-osmotic: prompts 
decreased actin fibres 
(depolymerised)  
Hyperosmotic: polymerised, 
with well defined fibres 
Blain, 2009, Chao et 
al., 2006, Erickson 
et al., 2003 
OA Less defined, disassembled and localised in the cytoplasm Li et al., 2007 
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Figure 1.3 The F-actin organisation of in situ bovine chondrocytes. 
 
Bovine articular cartilage explants were isolated from metacarpo-phalangeal joints and fixed 
in 4 % Para-formaldehyde, and labelled with Alexa-488 Phalloidin. Explants were visualized 
via CLSM. Chondrocytes from the three distance zones (A) SZ, (B) MZ, (C) DZ were 
presented. Actin was predominantly localised to the periphery of the cell. Bar = 5 µm 
  
 
A" B" C"
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1.3  Mechanotransduction in articular cartilage  
 
The main functions of articular cartilage are concerned with load-bearing 
(Urban, 1994) and articular chondrocytes are responsible for the mechanical 
properties of cartilage and its biochemical composition. They are the only 
resident cell type within the tissue and are responsible for matrix synthesis 
and turnover. During normal activities, loading pressure in cartilage may rise 
to 10-20 MPa within milliseconds (Milner, Wilkins and Gibson, 2012). Whilst 
this mechanical loading is essential for the synthesis of a viable ECM 
(Wilkins, 2000) excessive mechanical loading leads to cartilage damage and 
the formation of tissue lesions or fissures, that comprise the integrity of tissue 
and increase the risk of development of secondary OA (Chen et al., 2005, 
Griffin and Guilak, 2005, Verteramo and Seedhom, 2007, Bader et al., 2011, 
Goldring, 2012).  
 
Abnormal joint loading or simulated excessive mechanical loading utilising a 
drop-tower (where by a mass is dropped onto cartilage from a defined 
height), can result in imbalance in cartilage metabolism and can mimic the 
impact force experienced during high-impact trauma (Jeffrey et al., 1995, 
Aspden, 2002, Jeffrey and Aspden, 2006). High-impact mechanical loading 
leads to damage to the collagen network, resulting in tissue swelling and 
chondrocyte death through apoptosis or necrosis (Borrelli et al., 2003, Huser 
and Davies, 2006, Yeow et al., 2009, Han et al., 2011,). However, a 
complete understanding of the events involved in chondrocyte 
mechanotransduction is still unknown (Han et al., 2011, Mobasheri et al., 
2012). A number of stimuli including compression and shear stress are 
associated with alterations in the cell shape, with the actin cytoskeleton able 
to influence the capacity for volume regulation (Kerrigan and Hall, 2007, 
Raizman et al., 2010, Lewis et al., 2011). This process is linked to volume-
regulatory conditions including regulatory volume increase (RVI) and 
regulatory volume decrease (RVD; Jeffrey, 1995, Wilkins, 2000, Kerrigan et 
al., 2006, Lewis et al., 2011). During walking, the pressure on cartilage 
oscillates between 0.2 MPa and 0.5 MPa (Broom and Myers, 1980) thus 
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resulting in deformation of chondrocytes, leading to an increase in 
extracellular osmolarity, an effect that is reversible in healthy cartilage upon 
removal of the load (Maroudas and Bannon, 1981). Abnormal static 
compression (above 0.5 MPa) causes irreversible damage to cartilage and 
chondrocyte metabolic activities are impaired (Burton-Wurster et al., 1993, 
Guilak et al., 1994). Importantly pressure induces a set of cellular responses 
including calcium rise (Valhmu et al., 1998), up-regulation of aggrecan and 
collagen type II, and increased production of matrix metalloproteinase 3 
(MMP-3) (Lee et al., 1999, Sadler et al., 2000).   
1.3.1 Mechanotransduction and Volume Regulation  
 
The mechanisms by which chondrocytes alter their biological activity in 
response to joint loading are not fully understood but various biochemical 
and bio-physiological pathways are involved (Guilak et al., 2001, Mobasheri 
et al., 2012, Qusous et al., 2012). Normal physiological loading exposes 
chondrocytes to mechanical and osmotic stress, fluid pressure and fluid flow 
and in response to these stimuli. Water is exuded from the cartilage tissue 
and chondrocytes activate their volume regulatory mechanisms including 
RVD and RVI (Guilak, 1995, Kerrigan et al., 2006). Cell volume regulation is 
important to chondrocyte physiology and the mechanisms involved include 
the activation of membrane transporters that help cells to mediate dynamic 
volume equilibrium necessary for optimal physiological and metabolic 
process (Raizman et al., 2010, Lewis et al., 2011, Mobasheri et al., 2012). 
 
Freshly isolated and in situ chondrocytes have been reported to have limited 
response to RVI following hyperosmotic challenge compared to 2D cultured 
chondrocytes, suggesting that mechanotransduction mechanisms adapt with 
cell phenotype change (Kerrigan et al., 2007, Lewis, et al., 2011). The lack of 
RVI in in situ chondrocytes is not a phenomenon exclusive to this cell type as 
other cell types (e.g. lymphoid cells) (Hoffman et al., 2009) have been 
reported to express similar features. However this effect on RVI varies in its 
response to swelling between the cells from the different chondrocyte zones 
(Bush and Hall, 2003). 
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Since RVD and RVI mechanisms are poorly understood, it has been 
suggested that the disruption of RVD mechanism may be linked to the onset 
for OA, as decreased osmolarity induces cell swelling (Hall, 1995, Wilkins et 
al., 2000). Chondrocytes respond to volume decrease in a number of ways 
with activation of the Na+-K+-2Cl- co-transporter or other membrane co-
transporters (Hall, 1995). Intracellular calcium ion concentration plays a role 
in regulatory volume control (McCarty and O’Neil, 1992, Han et al., 2012) 
and it has been reported to increase in response to hyper-osmotic stress 
(Dascalu et al., 1995, Lang et al., 1998). In addition, Ca2+ is known to play a 
role in regulation of the Na+/H+ transporter and Ca2+/calmodulin complex thus 
triggering the RVI (Pedersen et al., 1996, Marchenko and Sage, 2000, Ong 
et al., 2010).  
1.3.2 Role of Calcium signalling in Mechanotransduction  
 
The role of calcium signalling in chondrocyte mechanotransduction has been 
studied intensively over the past few years and the role of this ubiquitous 
intracellular secondary messenger is diverse and dependent on numerous 
factors including: (1) principal zone, (2) morphology, (3) culture conditions 
and (4) phenotype (Han et al., 2012, Wann et al., 2012). [Ca2+]i has been 
linked to osmotic changes (Yelloweley et al., 1999, Kerrigan et al., 2006, Han 
et al., 2012), fluid flow (Yelloweley et al., 1999), pressure (Guilak et al., 
1999a) and membrane deformation (Guilak et al., 1999b). With osmotic 
changes resulting in an increase in [Ca2+]i shown to be mediated via the 
stretch-activated cation channel (SACC) induced by hypo-osmotic pressure 
(Kerrigan and Hall, 2008) and this response was inhibited by gadolinium 
chloride (GdCl3, a specific SACC inhibitor). Similar observations of induced 
increase in influx of Ca2+ into the cell via SACC and release of Ca2+ in the 
intracellular store were reported in relation to fluid flow (Yellowley et al., 1997, 
Yellowley et al., 1999).  Membrane deformation, as a result of fluid flow has 
been shown to induce an intracellular store - independent of a [Ca2+]i rise 
which was inhibited by pharmacological inhibitors (e.g. taurine, tamoxifen, 
calmodulin) of sodium calcium exchanger (NCX) and SACC (Guilak, 1999).  
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1.4 Osteoarthritis  
 
Osteoarthritis (OA) is the most common form of arthritis affecting millions of 
individuals worldwide (Goldring and Goldring, 2007, Loeser, 2011, Teeple et 
al., 2013). The total cost of osteoarthritis to UK economy calculated by 
National Institute for Health and Clinical Excellence (NICE) is estimated to be 
about 1 % of the annual gross national product (NICE) with a total cost 
estimated around £5.7 billion (ARC, 2008).   
 
OA is clinically referred to as a syndrome whose progression ultimately 
results in loss of cartilage function (Stockwell, 1991) and is associated with 
changes in the entire joint including the synovial joint lining, the surrounding 
connective tissue and cartilage (Loser, 2009). While the etiopathogensis of 
OA is not fully understood, historically the disease has been viewed as “wear 
and tear” disease, however studies suggest that OA involves a complex 
interplay of biochemical, mechanical and genetic factors (Pritchard and 
Guilak, 2006, Teeple et al., 2013). Within the tissue numerous morphological 
and molecular changes occur including increases in cartilage hydration, loss 
of PGs, surface disruption, changes in chondrocyte morphology (Bush et al., 
2003, Han et al., 2012), decrease in cell viability (Stockwell, 1991, Bush et 
al., 2005, Goldring and Marcu, 2009), changes in collagen synthesis 
(Goldring, 2007), and production of pro-inflammatory cytokines including IL-
1β, IL-6 and IL-8 as well as matrix-degrading enzymes (Fernandes et al., 
2002, Hedbom and Hauselmann, 2002, Goldring and Marcu, 2009, Natoli 
and Athanasiou, 2009, Goldring and Otero, 2011).  
 
In the first stage, of the pathology, OA is characterised with changes of the 
cartilage surface which is no longer smooth (McDevitt et al., 1977), as the 
disease progresses destruction of the collagen framework with subsequent 
loss of proteoglycans resulting in tissue hydration and elevations in 
chondrocyte volume leading to increased stiffness of the cartilage (Figure 
1.4). Cells from the SZ usually flat become round and disappear from the 
tissue (Goldring and Marcu, 2009, Lonrenz and Richter, 2006). During the 
second stage, chondrocytes respond to the altered conditions of the ECM 
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and proliferate in an attempt to repair the tissue (Newman, 1998, Lonrenz 
and Richter, 2006). In the final stage, there is a decreased response in 
chondrocyte repair mechanisms, potentially due to the mechanical damage 
to the chondrocytes resulting in complete loss of cartilage tissue as a 
consequence (Lonrenz and Richter, 2006). The cartilage surface is broken 
by fissures and cracks can reach down to the calcified zone, loss of PGs is 
evident and reaches the DZ and the tide mark zone becomes unclear 
(Lorenz et al., 2005, Goldring 2012a). At the cellular level, the presence of 
cytokines (IL-1β, TNFα, IL-6) and inflammatory mediators such as nitric oxide 
(NO), as well as matrix metalloproteinases (MMPs) lead to the synthesis and 
degradation of ECM (Tetlow et al., 2001, Fernandes et al., 2002, Bortner, 
2004, Goldring, 2012b). 
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Figure 1.4 Model of the role of mechanical stress and biological factors in the 
pathogenesis OA. 
 
Mechanical loading and biological factors such as aging result in tissue damage that induces 
increase of Collagen II (col2), proteoglycans (PGs) and matrix metalloproteinases (MMPs) 
production. Due to loss of the PGs the increased level of fluid causes cell swelling and the 
matrix fragmentation induces production of MMPs that result in further degradation of the 
extracellular matrix (ECM). To respond to the environmental changes, the chondrocytes 
release IL-1 that increases the effects on the matrix degradation and stimulates further 
production of IL-1.  (Adapted from Goldring and Marcu, 2009).   
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1.4.1 Cell Death, Mechanical Load and Osteoarthritis 
 
The pathogenesis of OA is still unclear and while mechanical load is an 
important regulator of cell function it can induce inflammatory mediators (IL-
1β, NO) and MMP's (Fermor, 2001, Lotz, 2004), hence attempts have been 
made to distinguish between the type of death in response to mechanical 
load and inflammatory mediators. Apoptosis and necrosis are the two types 
of death that have been contrasted mechanically (Table 1.2). Apoptosis is 
programmed cell death, which could be physiological (cell renewal) or 
pathological (Kühn et al., 2004, Kruz et al., 2005). During the process of 
apoptosis cells loose their volume – termed apoptotic volume decrease 
(AVD; Aigner and Kim, 2002, Bortner, 2004) followed by condensation of 
cytoplasm and nucleosomal cleavage. This leads to mechanisms that results 
in controlled breakdown of the cell into apoptotic bodies, which are 
subsequently engulfed by phagocytes (Duprez et al., 2009).  
 
This cellular ‘suicide’ mechanism in mammalian cells can be activated by the 
intrinsic or extrinsic pathway (Duprez et al., 2009) with various stimuli  (e.g. 
cytotoxic insults or DNA fragmentation) triggering the intrinsic pathway 
leading to Bcl-2 protein family activation, whereby anti-apoptotic Bcl-2 
proteins (Bax) inhibit pro-apoptosis. Once Bcl-2 proteins are activated via the 
intrinsic factors Bax, Bak inhibition is removed thus leading to formation of 
channels via which cytochrome c (cyt c) is released in the cytosol and 
associates with Apaf-1 and ATP, thus activating the enzymes crucial for the 
apoptotic cell death the ‘executioner Caspases’ (Caspase-3,-6 and-7) (Riedl 
and Salvesen, 2007, Youle and Strasser, 2008). 
 
Stimulation of the extrinsic pathway leads to activation of ‘death receptors’ 
that belong to TNFR family (Fas, TNFR and Trail-R). Apoptosis is induced 
via the formation of death inducing signalling complex (DISC) that includes 
Fas associated death domain (FADD), which activates Caspase-8 and/or -10 
and in turn activates the ‘executioner Caspases’ (Figure 1.5; Duprez et al., 
2009). 
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Table 1.2 Distinguishing features of apoptosis and necrosis. 
 
Apoptosis and necrosis comprise a partially overlapping spectrum of characteristics. Criteria 
that distinguish apoptosis and necrosis are summarised here. (Table adapted from Kühn et 
al., 2004). 
 
 
Type of cell 
death  
 
Distinguishing Features  
 
Morphologic Features  Physiologic Characteristics 
 
 
 
Apoptosis 
 
 
 
• Shrinking of cytoplasm 
and chromatin 
condensation 
• Nuclear fragmentation 
• Formation of apoptotic 
bodies  
• Affects individual cells  
• Tightly regulated 
signalling events 
• Energy dependent 
• Enzymatically 
catalysed changes 
of cell membrane 
• Orderly 
fragmentation of 
DNA 
• Activation of 
caspases  
• Late loss of 
membrane integrity  
 
Necrosis  
 
 
• Swelling of cytoplasm 
and mitochondria  
• Total cellular 
disintegration  
• Affects groups of cells 
 
 
• Early loss of 
membrane integrity  
• No energy 
requirement 
• Random 
destruction of DNA 
• DNA degradation 
occurs after 
membrane 
permeabilization  
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Figure 1.5 Schematic representation of apoptotic signalling. 
  
(1) Extrinsic signalling pathway stimulation is initiated upon stimulation of death receptors 
(e.g. Fas, TNFR1), a death –inducing signalling complex (DISC) is formed and nuclear factor 
NFkß activated thus resulting in transcription of anti-apoptotic genes. Fas-associated death 
domain (FADD) as one of the main components of DISC activates Caspases-8,-10 which 
subsequently activate Caspases-3,-6,-7 also known as executioner Caspases. Nevertheless, 
Caspase-8 elucidates the cleavage of anti –apoptotic BCl-2 protein family thus activating the 
intrinsic pathway (2). (2) Stimulation of the intracellular stress activates Bax/Bac, which 
results in production of cytochorome c (cyt c). Cyt c predisposes the formation of 
apoptosome responsible for activation of Caspase-9 and the executioner Caspases-3,-6,-7 
(Duprez et al., 2009, Youle and Strasser, 2008). Adapted from Duprez et al., 2009. 
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Whilst apoptosis is programmed cell death, necrosis, is a consequence of 
pathologic incident and does not require specific intracellular signalling; 
therefore it is referred to as non-programmed ‘accidental’ or ‘uncontrolled’ 
cell death. Unlike apoptosis, it does not require activation of specific 
intracellular signalling (Kühn et al., 2004) and can be characterised as a form 
of caspase-independent cell death by gain of cell volume, organelle swelling 
(e.g. mitochondria), followed by loss of membrane integrity which leads to 
cellular disintegration and random fragmentation of nuclear DNA that occurs 
following membrane rupture and release of intracellular contents into the 
extracellular space (Kruz et al., 2004, Duprez et al., 2009, Kaczmarek et al., 
2013). Chondrocytes die via necrosis after direct mechanical insult or by 
apoptosis with studies suggesting that necrosis could be triggered via the 
TNFR in the presence of Caspase inhibition thus suggesting that necrosis 
could also be a cell-mediated form of cell death thereby termed necroptosis 
(Christofferson and Yuan, 2010, Gong et al., 2013, Kaczmarek, 2013). 
Numerous mediators are involved in the execution of necrosis (and 
necroptosis), including reactive oxygen species (ROS), calcium (Ca2+), 
calpains, cathepsins, phospholipases, and ceramide (Degterev et al., 2005, 
Vanlangenakker et al., 2012). 
 
Apoptosis has been documented to occur in OA (Goggs et al., 2003), 
however its cause and contribution to the pathogenesis of the disease are 
yet to be revealed. A number of stimuli currently presently of interest e.g. 
nitric oxide (NO), TNF-α, IL-1 and mechanical stress. The effect of NO 
requires further study but is has variable consequences on apoptosis either 
prompting or preventing it (Borter, 2004). NO induces AVD and can alter the 
actin cytoskeleton, with the cytokines IL-1β and IL-6 being able to elevate NO 
(Lotz, 2003, Borter, 2004, Kurz, 2005). Although NO has been shown to 
either prompt or prevent apoptosis and can be induced by IL-1β and TNF-α, 
which are associated with the inflammatory effects observed in OA (Lotz, 
2003, Borter, 2004, Kurz, 2005, Goldring and Otero, 2011, Goldring et al., 
2012). These cytokines disturb the reconstruction of articular cartilage by 
elucidating the production of MMPs and aggrecanases (also known as 
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ADAMTS) that cleave all kinds of ECM proteins, collagen and the PGs 
network thus limiting the anabolism of the ECM (Goldring et al., 2012, Loser 
et al., 2012). 
 
NO donors induce chondrocyte apoptosis and increase cyclooxygenase 2 
(COX-2) expression stimulating increases in postaglandin E2 (PGE2), 
(Gosset et al., 2008, Loser et al., 2012). Although, the role of PGE2 is still 
unclear it has been reported to induce apoptosis in healthy bovine articular 
cartilage (Goggs et al., 2003, Jeffrey and Aspden, 2007). Furthermore, the 
presence of pro-inflammatory mediators such as IL-1β and TNF-α found 
within OA joints and synovial fluid have a significant effect on cartilage 
metabolism and act directly on chondrocyte catabolism leading to increased 
expression of MMPs (Sabatini et al., 2000, Gosset et al., 2008) and 
apoptosis (Blanco et al., 2011, Loser et al., 2012). 
 
Mechanical loading can trigger apoptosis whereby extensive loads lead to 
cell necrosis as well as structural damage (Chen et al., 2001, Torzilli et al., 
2001, Borrelli, 2006, Stolberg et al., 2013) with pressures as low as 4.5 MPa 
(Loening et al., 2000) inducing apoptosis. Furthermore, it has been shown 
that mechanical stress can induce a biphasic cell death that is both necrotic 
and apoptotic. Research by D'Lima and Tew have suggested that initial 
chondrocyte death induced by mechanical trauma (within the first 6 h) is 
necrotic as no significant difference was detected in apoptotic cell death, 
conversely apoptosis has been reported to increase by 30 % at 96 h post 
mechanical load (D’Lima et al., 1998, Tew et al., 2000). 
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1.4.2 Mechanical trauma and cell viability  
 
Within articular cartilage, the chondrocyte cytoskeleton is a dynamic three-
dimensional (3D) network capable of withstanding mechanical stress 
(Durrant, 1999, Goldring, 2000, Kurz et al., 2005). In vivo the levels of stress 
can be considerable, for example, the physiological load measured in the 
human femoral head varies between 2-4 MPa, during normal walking (Hodge 
et al, 1986) whilst during running and jumping these levels vary between 20-
40 MPa (Hodge et al, 1986, Aspden et al., 2004, Grodzinsky, 2005). 
Understanding the physiology and pathology of articular cartilage in order to 
understand the aetiology of OA is paramount. Animal models of OA have 
shown that impact loading above the normal range can cause damage to the 
extracellular matrix (ECM) leading to increased water content (Torzilli et al, 
1999, Kruz et al., 2001). Cartilage swelling and collagen damage, decreased 
stiffness (Kruz et al., 2000, Kruz et al., 2001, Chen et al., 2005), loss of 
glycosaminoglycans (GAGs) (Quinn et al., 1998, Torzilli et al, 1999), tissue 
loss, up and down regulation of gene expression, cell death as well as 
initiation of cartilage degradation and development of OA (Gulak, 1995, 
Buckwlter and Mankin, 1997, D’Lima et al., 2001a, Bush and Hall, 2005, 
Aspden et al., 2006, Goldring, 2012a). 
 
Mechanical impact or joint overuse has also been reported to be responsible 
for cartilage fissures and lesions (Figure 1.6; Radin et al., 1981, Donohue et 
al., 1983, Bush and Hall, 2003, Bush et al., 2005) thus suggesting that 
mechanical OA could be initiated from repeated impacts. With biochemical 
and morphological nature of the disease showing a possible ‘pre-
osteoarthritic state’ in relation to the over use induced joint damage (Vasan, 
1983, Brown et al., 1984, Lammi et al., 1993, Lequesne et al., 1997). These 
findings have been further supported with high impact sport including football 
(Lindberg et al., 1993, Vingared et al., 1993, Roos et al., 1994), weightlifting, 
running and boxing (Kujala et al., 1994, Kujala et al., 1995), displaying an 
increased risk of OA in knee and hip joints.  
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Figure 1.6 Overview of chondrocyte death arising from the application of single 
impact load to bovine cartilage. 
 
(A) Healthy non impacted bovine cartilage tissue. 
  
(B) Single injurious impact damaged the cartilage by causing fissures and lesions to occur. 
Green spots represent live cells, red spots represent dead cells images were acquired by 
axial confocal laser scanning microscopy (CLSM) projections imaging the superficial zone of 
cartilage ‘top-down’ from the articular surface. Bar = 100 µm 
.   
(A) (B) 
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Acute mechanical traumatic joint injury in terms of sport injury or traffic 
accident is thought to be one of the factors in the development of secondary 
OA (Borrelli, 2006). Articular cartilage has poor repair potential and generally 
does not repair (Buckwalter and Mankin 1997, Newman, 1998, Grodzinsky, 
2005) whereby acute traumatic lessons may occur as a consequence of 
intra-articular fracture and high-impact injury, or following ligament injury, and 
are believed to be factors that lead to the development of secondary OA 
(Hunzinker, 2002, Mankin et al., 2000, Borrelli, 2006). Other factors include 
inflammation, genetic predisposition, female gender, obesity, or occupational 
hazards (Davis et al., 1989, Kurz, 2005, Buckwalter, 2006, Goldring and 
Marcu, 2009, Iannone and Lapaduda, 2010, Goldring and Otero, 2011).   
 
OA is a degenerative disease with well-known final stages however, the early 
stages and the triggers of the degenerative pathway are yet to be elucidated. 
The disease is characterised by progressive degeneration of articular 
cartilage leading to chronic joint pain and restrictions of joint function in the 
affected joints (Buckwalter, 1995, Aspden, 2006, Richter and Lorenz, 2006), 
accompanied with sclerosis and remodelling of subchondral bone and 
formation of cysts (Johnston, 1997, Buckwalter, 2006). Nevertheless, the 
only current treatment is arthroplasty and the mechanism of the progression 
of the disease is still unknown.     
 
Over the last decade, several animal models have been established to 
investigate the mechanism of mechanical overload and injury (Kruz et al., 
2005, Amin et al., 2011, Poulet et al., 2011). Single impact loading (simulated 
by using drop tower) is a research technique used to study the mechanism of 
chondrocyte cell death as a model of cartilage damage by utilizing, various 
heights and weights (Bush and Hall, 2005, Aspen 2006, Huser and Davis 
2006, Jeffrey, 2006, Vertramo and Sheedhom, 2007, Henson and Vincent 
2008, Martin et al., 2009, Yeow et al., 2010, Henson et al., 2012). 
Chondrocyte cell death has a major impact on degeneration of articular 
cartilage and is dependent on strain rate and mechanical load (Aspden et al., 
2006).  
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Mechanical injury has been found to influence the biosynthetic activity of 
articular cartilage using numerous models to simulate mechanical overload 
(Bush et al., 2005, Jeffrey and Aspden, 2006, Huser and Davis 2007, 
Henson and Vincent 2008, Martin et al., 2009, Henson et al., 2012). 
Importantly, it is recognised that injury does not only influence the 
biosynthetic activity directly but can also influence the chondrocytes ability to 
respond (Henson et al., 2012). Studies suggest that chondrocyte death and 
viability are closely linked to ECM integrity and induce high levels of cartilage 
injury resulting in cell death (necrosis, apoptosis, or both) and release of PG 
(Loening et al., 2001, Lotz, 2004, Bush et al., 2005, Grodzinsky et al., 2005, 
Martin et al., 2009). Previous studies utilising mechanical models of in situ 
chondrocytes showed that the key effect on morphology is cell volume, 
decreases in cell volume renders the cell less susceptible to mechanical 
load. Conversely, swelling of in situ chondrocytes by reduced osmolarity 
elevates their sensitivity to mechanical load and increases cell death (Bush 
and Hall, 2003, Bush et al., 2005, Amin et al., 2008).  
 
 
 
 
 
 
   
 
 
 
 
 
 
 
 
 
 
 
INTRODUCTION! 27 
 
  
 
 
 
 
 
 
 
 
AIMS 
 
The aim of this study is to determine the role of single mechanical impact 
injury in the first stages of post mechanical trauma, the role that the actin 
cytoskeleton and [Ca2+]i play and identification of a novel chondro-protective 
agent  following single impact load injury. 
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2.1 Materials  
2.1.1 Tissue and Cell Culture  
 
Table 2.1 Reagents for tissue culture. 
 
2.1.2 Fluorophores used   
 
 Table 2.2 Fluorophores used for CLSM. 
 
NAME COMPANY PRODUCT CODE 
WORKING 
CONCENTRATION 
Dulbecco’s Modified 
Eagle Medium 
(DMEM) 
Sigma-Aldrich, 
Poole, UK D6171 N/A 
Penicillin / 
Streptomycin 
Solution 
Sigma-Aldrich, 
Poole, UK P0781 1 % 
Sodium Chloride Fisher Scientific, Loughborough, UK S13160/65 
Varied; depending upon the 
experimental protocol 
Trypsin-EDTA Invitrogen, Paisley, UK 25300 0.05 % 
Spirit, Methylated VWR, Lutterworth, UK 302444E N/A 
Collagenase  Sigma-Aldrich, Poole, UK C0773 0.08 g 
Trypan Blue Sigma-Aldrich, Poole, UK T8154 0.4 % 
NAME COMPANY PRODUCT CODE 
WORKING 
CONCENTRATION 
Calcein-AM Anaspec Inc, Freemont, USA 89201 5 µM 
Alexa 488 
(conjugated to 
phalloidin) 
Invitrogen, Paisley, 
UK A12379 35 nM 
Propidium Iodide Invitrogen, Paisley, UK P1304MP 1 µM 
Fluo-4, AM Invitrogen, Paisley, 
UK 
F14201 2 µM 
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2.1.3 Cytoskeletal Studies 
 
 
Table 2.3 Reagents used to study actin cytoskeleton. 
2.1.4 Molecular Biology Reagents 
 
 
Table 2.4 Reagents used for RNA extraction, reverse transcription of RNA and cDNA 
PCR. 
 
NAME COMPANY PRODUCT CODE 
WORKING 
CONCENTRATION 
Ammonium 
Chloride 
Sigma-Aldrich, Poole, 
UK A0171 50 mM 
Bovine Serum 
Albumin 
Sigma-Aldrich, Poole, 
UK A2153 1 % 
Glycine Fisher Scientific, Loughborough, UK BPE381 100 mM 
Para-
formaldehyde 
Sigma-Aldrich, Poole, 
UK 533998 4 % 
Phosphate Buffer 
Saline 
Fisher Scientific, 
Loughborough, UK BR0014G N/A 
Triton x100 Fisher Scientific, Loughborough, UK ZT3751 0.5 % 
Tween 20 Fisher Scientific, Loughborough, UK BPE337 0.05 % 
NAME COMPANY PRODUCT CODE 
WORKING 
CONCENTRATION 
Nucleospin®  MACHERY-NAGEL, DÜren, Germany 740 933 N/A 
Absolute Ethanol  VWR, Lutterworth, UK 10107 70 % 
Agarose  Fisher Scientific, Loughborough, UK BP1356 2 % 
Quick-Load® 100 bp 
DNA Ladder 
New England 
Biolabs, Hitchin, UK N0467S N/A 
GoTaq® Green 
Master Mix 
Promega 
Corporation, 
Southampton, UK 
M7112 N/A 
ImProm-IITM 
Promega 
Corporation, 
Southampton, UK 
A3800 N/A 
2-Mercaptoethanol Fisher Scientific, Loughborough, UK BP176 2 % 
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 Table 2.5 Western blot reagents. 
 
 
 
 
 
NAME COMPANY PRODUCT CODE 
WORKING 
CONCENTRATION 
NuPAGE® 10 % 
Bis-Tris Gel  
Invitrogen, Paisley, 
UK NP0301 N/A 
NuPAGE® Running 
Buffer (20x) 
Invitrogen, Paisley, 
UK NP0001 N/A 
NuPAGE® Transfer 
Buffer (20x) 
Invitrogen, Paisley, 
UK NP0006 N/A 
NuPAGE® LDS 
Buffer (4x) 
Promega 
Corporation, 
Southampton, UK 
NP0007 N/A 
Full Range 
RainbowTM Weight 
Marker  
GE Healthcare, 
Amersham, UK RPN800 N/A 
Pierce®ELC 
Western Blotting 
Substrate 
Fisher Scientific, 
Loughborough, UK 10322094 N/A 
Kodak Developer 
and replenisher 
Kodak, Hemel 
Hempstead, UK 190 0943 N/A 
Kodak Fixer and 
replenisher  
Kodak, Hemel 
Hempstead, UK 190 1875 N/A 
Hot Lysis Buffer  See Appendix III N/A N/A 
TBST Buffer  See Appendix III N/A N/A 
Methanol  Fisher Scientific, Loughborough, UK N/A N/A 
Skimmed milk  Sainsbury’s, London, UK N/A 5 % 
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Table 2.6 Antibodies used.  
 
 
 
 
 
 
 
NAME COMPANY PRODUCT CODE 
WORKING 
CONCENTRATION 
Monoclonal Anti-α-
Tubulin CloneB-5-1-2 
Sigma-Aldrich, 
Poole, UK T5168 1:2000 
Polyclonal Goat Anti-
mouse 
Immunoglobullins/ HRP 
Dako Cytomation, 
Glostrup, Denmark DK-2600 1:2000 
Anti-rabbit IgG, HRP-
linked Antibody 
Cell Signalling 
Technology, 
Danvers, USA 
7074 1:2000 
P-Cofilin Antibody Cell Signalling Technology, 
Danvers, USA 
3313S 1:2000 
Cofilin Antibody Cell Signalling Technology, 
Danvers, USA 
5175S 1:2000 
Profilin-1 Antibody 
Cell Signalling 
Technology, 
Danvers, USA 
3237 1:2000 
Gelsolin Abcam, Cambridge, UK Ab74420 1:2000 
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2.1.5 Pharmacological Reagents 
 
 
 
 
 
Table 2.7 Reagents used.  
 
 
NAME COMPANY PRODUCT CODE 
WORKING 
CONCENTR
ATION 
REFERENCE
S 
Dimethyl 
Sulphoxide 
Fisher Scientific, 
Loughborough, 
UK 
D4121 0.1 % - 
Ethylene 
glycol 
tetraacetic 
acid (EGTA) 
Sigma-Aldrich, 
Poole, UK E0396 2 mM 
(Erickson et al., 
2000, Kerrigan 
and Hall, 2008) 
Gadolinium 
(III) chloride 
Sigma-Aldrich, 
Poole, UK G7532 100 µM 
Kerrigan and Hall, 
2006) 
REV5901 Sigma-Aldrich, Poole, UK R5523 50 µM 
(Bush and Hall, 
2001a, Musser et 
al., 1987, Van 
Inwegen et al., 
1987 
REV5901 
para-isomer  
(L-655,238) 
Enzo® Life 
Sciences, 
Exeter, UK  
BML_El210_
0010  50 µM 
(Bush and Hall, 
2001a) 
Jasplakinolide Invitrogen, Paisley, UK J7473 5 µM 
(Bubb et al., 
1994) 
Wortmannin Sigma-Aldrich, Poole, UK W1628 10 nM 
(Starkman, et al., 
2005) 
Uridine  Sigma-Aldrich, Poole, UK U6381 100 µM 
(Koolpe et al., 
2005) 
Lantraculin B Sigma-Aldrich, Poole, UK L5288 10 µM 
(Coue et al., 
1987, Kerrigan 
and Hall, 2005) 
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2.1.6 Biochemical and Experimental Solutions  
 
Cartilage explants were isolated in serum-free Dulbecco’s Modified Eagle 
Medium (DMEM) containing penicillin (100 units.ml-1) and streptomycin (50 
µg.ml-1) pH 7.4; 280 mOms, Calcein-AM (5 µM), propidium iodide  (1 µM) 
and Alexa phalloidin (5 µM) were used to visualise chondrocytes by Confocal 
Laser Scanning Microscopy (CLSM). These fluorescent indicators were used 
in stock solutions prepared in dimethylsulfoxide (DMSO), deionised distilled 
water or methanol, respectively.   
 
Filter-sterilised 50 mM sodium chloride (NaCl) was used for the preparation 
of hypertonic DMEM (various osmotic challenges) and osmolarity was 
measured using a VaproTM vapor pressure osmometer. A stock solution of 
gadolinium chloride (GdCl3), 10 mM was prepared in water, REV 5901 was 
reconstituted into DMSO to a working concentration of 50 µM, L-665,238 
reconstituted into DMSO to a working concentration of 50 µM, wortmaninn, 
uridine also reconstructed in DMSO with working concentration of 10nM and 
100 µM. 
 
In experiments that involved the removal of extracellular calcium ([Ca2+]0)  a 
basic physiological saline (BPS) was used containing: glucose (10 mM), 
potassium chloride  (KCl; 5 mM), magnesium chloride (MgCl2; 1 mM), 
HEPES (1 mM) and ethylene glycol tetraacetic acid (EGTA; 2 mM). For a 
paired control the above solution was used whereby the EGTA was 
substituted by the addition of calcium chloride (CaCl2; 1 mM). All solutions 
were adjusted to a pH of 7.4 ± 0.05 using sodium hydroxide (NaOH). The 
osmolarity of all solutions was measured using a VaproTM vapour pressure 
osmometer and adjusted by the addition of NaCl to +/- 5 Osm of the desired 
osmolarity.  
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2.2 Methods 
2.2.1 Bovine dissection and isolation of explants and primary 
chondrocytes 
 
Bovine articular cartilage was removed from load-bearing regions of the 
metacarpal-phalangeal joints of 18-21 months old female animals on the day 
of slaughter (obtained from local abattoir with ethical permission and used 
within 3 days). The hoof and skin were removed before the exposure of the 
joint capsule (Figure 2.1), cartilage explants, without subchondral bone, were 
removed under aseptic condition and placed in 280 mOsm DMEM, 
supplemented with 1 % penicillin and streptomycin. Fresh scalpels were 
used to minimise cell damage as previously described and cartilage explants 
were allowed to recover overnight (Bush and Hall, 2005, Kerrigan and Hall, 
2005, Amin et al., 2010).  
 
In order to obtain primary chondrocytes cartilage explants were excised from 
bovine legs using several animals and pooled chondrocytes were isolated 
from explants by overnight incubation (18-20 h) with collagenase (Sigma-
Aldrich, Poole, UK; 0.8 mg ml-1 DMEM). Cells were kept in 380 mOsm 
DMEM whereby the osmolarity of the DMEM was raised by the addition of 
NaCl to prevent chondrocyte swelling due to their release from the matrix 
(Hall, 1996). The digest was then passed through a 20 µm nylon filter and 
washed 3x by centrifugation (8 min, 500g) and chondrocytes were cultured. 
Absolute cell number used for PCR experiments was 5 x 106 cells, 1 x 106 
cells for Western blot analysis and CLSM examinations were performed at 1 
x 104 cell number.  
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Figure 2.1 Cartilage removal. 
 
Full depth explants were removed from the apical surface of metacarpal joint of bovine 
animals under aseptic conditions. Explants were allowed to rest at 37o C and 5 % CO2 in 
DMEM for overnight (Bush and Hall, 2001a). 
  
 
 
 
 
 
 
 
MATERIALS8AND8METHODS! 37 
!
  
2.2.2 Impact Tower and Calculation of Impact Energy 
 
In order to investigate the effect of blunt trauma on articular cartilage cells 
individual explants were subject to a single impact trauma by using a ‘drop 
tower’ following a previously reported protocol (Gregory et al., 1995, Jeffrey 
et al., 1995, Bush et al., 2005). The drop tower, (Figure 2.2) was constructed 
of three vertical parallel steal rods in which an impactor could fall freely with 
minimum friction therefore, a known mass could be dropped onto a sample 
of cartilage from a known height (Jeffrey et al., 1995, Bush and Hall, 2005). 
 
The impact force pressure was calculated assuming linear acceleration 
under gravity and it was calculated that an impact force pressure of 1.34 N is 
the result of known mass (134 g) and height (10 cm) of the ‘drop’ carried out 
on the cartilage sample (Table 2.8). Following a single impact, cartilage 
explants were removed from the drop tower and placed flat on a dish and 
viewed at a perpendicular angel to the synovial (articular) surface. To insure 
that the tissue was prevented from moving during the image acquisition 
process, cyano-acrylic glue (Bostik Ltd, Leicester, UK) was applied to one 
edge of the sample. 
 
The values above are significantly lower compared to values published in the 
literature regarding in vivo joint forces but these values have been optimised 
to allow for studying cell death as a result of a blunt trauma for articular 
cartilage explants, as they do not tend to destroy the tissue thus giving the 
opportunity to measure cell death. In addition, articular cartilage within an in 
vivo environment would be supported by bone and protected by synovial 
fluid thus allowing cartilage to withstand greater forces. However, the impact 
tower model is not designed to be an exact model for mimicking the in vivo 
process but is a suitable model to study the effects of blunt mechanical 
trauma on articular cartilage (Jeffrey et al., 1995). 
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Figure 2.2 Drop tower for cartilage impact. 
 
The tower was constructed of three rods, impactor (shown in motion) and the base of the 
tower are made of hard nylon polished to a smooth finish (I would like to thank Dr. Andrew C 
Hall at the University of Edinburgh for the use of the drop tower).  
 
 
 
Table 2.8 Impact energy and velocity corresponding to mass and height. 
 
Values were calculated using physics equations and they are theoretical where by, force 
was calculated from the known mass and the acceleration (F=ma). Pressure was calculated 
from the force and the base (‘drop’) area (1.77 cm2) of the impact tower. 
 
MASS  
(g) 
DROP 
HEIGHT  
(cm) 
IMPACT 
VELOCITY 
 (m/s) 
ENERGY  
(J) 
FORCE  
(N) 
PRESSURE 
(MPa) 
134 5 0.99 0.070 0.070 4 x10-3 
134 10 1.40 0.132 1.32 7.5x10-3 
134 20 1.98 0.263 0.263 15 x10-3 
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Figure 2.3 Cell response post impact from different heights. 
 
Full depth cartilage explants were subject to a single impact by using the impact 
tower. Non-impact and impact (5-20 cm) tissue using 134 g was used and cell 
viability determined by CLSM. Explants were incubated with 5 µM calcein-AM and 
propidium iodide 1 µM prior to visualisation and samples were imaged at 2, 5, 10, 
15 and 25 min post impact. The number of dead cells was expressed as 
percentage of the total cell number. Data are mean +/- SEM, N=6 from 3 distinct 
experiments. Statistical analysis (Student’s unpaired t-tests) were given as *p< 
0.05, **p< 0.01 and ***p< 0.001 all versus 5 cm impact.  
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2.2.3 Preparation of Tissue and Primary Cells for Confocal 
microscopy 
 
Confocal Laser Scanning Microscopy (CLSM) is a technique that has found 
tremendous utility in in vitro three-dimensional imaging (3D). Confocal 
microscopy provides an opportunity to collect high-resolution, 3D images that 
follow dynamic cellular changes over periods of time (Semwogerere and 
Weeks, 2005, Kerrigan and Hall, 2008). The fundamentals of CLSM date 
back from 1955 when Marvin Minsky, a Fellow from Harvard University, 
reported a point-by-point image construction by focusing a point of light 
sequentially across a specimen and then collecting some of the reflecting 
rays (Leica, 2004, Semwogerere and Weeks, 2005). Confocal microscopes 
use a laser light source focused onto a focal point of the specimen surface 
being imaged by the objective lens. Photons are emitted from the 
fluorophore, used to stain the specimen and collected through the objective 
separated into the detection aperture via a ‘pinhole’. The ‘pinhole’ is the 
critical part of the CLSM where by out-of-focus light rays are obstructed, thus 
creating very clear and sharp images within a 3D space.  
 
The ability of confocal microscopes to create sharp images of optical 
sections makes possible the construction of 3D images by assembling the 
data gathered from a series of successive focal panels (termed a z-stack), 
which can be used to investigate changes in cell volume, cell survival and 
actin cytoskeleton. Full depth explants and freshly isolated cells were 
visualised using an upright Leica SP2 CLSM (Leica Microsystems, Milton 
Keynes, UK) and image acquisition collected as previously described (Bush 
et al., 2005, Kerrigan and Hall, 2008). Images acquired on the CLSM were 
reassembled and analysed on Imaris software 7.4 (Bitplane, Zurich, 
Switzerland). All images were acquired at a resolution of 1024x1024 pixels 
using an optimal pinhole radius of 1 Airy unit, which is defined as the 
diameter of the Airy disk for each given objective (Semwogerere and Weeks, 
2005, Ramshesh and Lemasters, 2008). Simply, an Airy disc is a diffraction 
pattern created by the sample under the microscope and is another way to 
describe the resolution of the microscope. By adjusting the pinhole diameter 
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of the Airy disc, or 1 Airy unit signal to noise ratio of the light from the sample 
is high and thus resulting in optimal acquisition. 
 
 
 
 
Figure 2.4 Confocal Microscope Optical Path. 
 
Confocal microscopes use a laser light source that is focused onto a focal point of 
the specimen surface being imaged by the objective lens. Adsorbance of excited 
light results in the release of an emitted photon reemitted from the fluorophore 
used to stain the specimen and collected through the objective separated into the 
detection aperture by the beam splitter and passed through the ‘pinhole’, this 
obstructs ‘out-of-focus light rays, thus creating very sharp images. The light signal 
coming from the specimen is recorded into a detector (photomultiplier tube) that 
converts light into electrical signal able to be interpreted by computer.  
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2.2.3.1 Preparation of Tissue for Imaging cell survival following 
Impact   
 
Prior to experimentation, cartilage explants were incubated with Calcein-AM 
to determine living cells and propidium iodide (PI) for dead/dying cells (30 
min, 37o C, 5 µM and 1 µM, respectively). Calcein-AM is a membrane-
permeant and non-fluorescent but, upon cell entry in leaving cells, the AM-
group is cleaved by intracellular esterases and the fluorophore calcein is 
released in an impermanent form (Grynkiewicz et al., 1985). Conversely, PI 
is a membrane impermanent dye generally excluded from live cells and as 
such is only able to bind to DNA (the target molecule), when the cell 
membrane becomes permeable; a process that occurs early during cell 
death (Bush et al., 2005).  
 
Following impact, explants were attached to a 22 mm dish with cyano-acrylic 
glue (Bostik Ltd, Leicester, UK) and fresh 280 mOsm DMEM added and the 
plastic dish placed onto a heated stage (37o C) of an upright Leica SP2 
CLSM (Leica Microsystems, Milton Keynes, UK). Images were acquired 
using a x10 dry objective lens, at a resolution of 1024 x 1024 pixels with 
calcein excited at 488 nm (argon laser; Figure 2.5) and the emission 
recorded through a bandpass filter 510-525 nm. Propidium iodide excited at 
543 nm (He-Ne laser; Figure 2.5) with the emission recorded through a 
bandpass filter 660-709 nm. For the generation of 3D images a z-step of 5.0 
µm was used along the Z-axis. To eliminate the potential effect of ‘bleed-
through’ (overlap between emission spectra) between calcein and PI that 
could lead to false images of samples stained with both fluorophores 
sequential imaging was used. The technique obstructs ‘bleed-through’ by the 
consecutive excitation of the fluorophores instead of simultaneous excitation 
thus ensuring that the image taken is solely from the emitting fluorophore 
and not from the second fluorophore (Leica 2006, Ramshesh and Lemasters, 
2008). 
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2.2.3.2 Preparation of Freshly Isolated explants or Primary Cells 
for Imaging Cell volume and morphology  
 
Freshly isolated explants/cells were prepared at a low density 1 x 104 into 22 
mm dishes and incubated with Calcein-AM (30 min, 37o C; 5 µM) and the 
excessive, non-incorporated fluorophore removed by washing with 280 
mOsm fresh DMEM. Dishes were subsequently placed onto a heated stage 
(37o C) of the CLSM and images acquired using a x63 immersion objective 
lens (NA=0.63), at a resolution of 1024 x 1024 pixels. 3D images were 
generated with z-stack series acquired using 1.0 µm intervals along the z-
axis.  
2.2.3.3 Preparation of Tissue or Primary cells for cytoskeletal 
staining   
 
To investigate the effects of impact trauma on actin cytoskeleton 
organisation a modified, method previously described, was used (Kerrigan 
and Hall, 2005). Cartilage tissue/cell cultures were fixed with 4 % ice-cold 
paraformaldehyde (PFA) for 30 min at room temperature and then washed 
3X with ice-cold PBS to remove the excesses PFA. Actin labelling was based 
on the Triton method using the fluorophore Alexa 488-phalloidin. Samples 
were quenched for 10 min in ice-cold NH4Cl followed by subsequent 
permeablisation using 0.1 % Triton X100 in PBS for 5 min under gentle 
agitation, rinsed in 100 mM glycine to stop the permeabilisation and washed 
3x with PBS before being blocked with 1 % bovine serum albumin (BSA) and 
0.05 % Tween-20 in PBS for 30 min. F-actin was labelled with Alexa 488-
phalloidin (5 µl/ml) under gentle agitation for 45 min in the dark. After 
labelling, excessive dye was removed by washing 3X in ice-cold 0.05 % 
Tween-20 in PBS and stored at 40 C until required for imaging; within 24 h. 
The fluorophore Alexa 488-phalloidin was excited using a 488 nm laser 
(Argon-laser; Figure 2.5) and images acquired using a x63 water-emersion 
objective at samples 1024 x 1024 pixels, with a z-step of 0.3 µm. To reduce 
the signal to noise ratio average of 4x zoom was used for every cell.  
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Figure 2.5 Excitation and Emission spectra for Calcein-AM, Propidium Iodide (PI) and 
Alexa Fluor 488 Phalloidin. 
 
Excitation spectra for the fluorophores used wavelengths of 488 nm for both Calcein and 
Alexa 488 phalloidin (A&C), and 543 nm for PI (B). Emissions optimal pass band was 
observed to be 510-590 for Calcein and 570-710 for PI thus presenting a possibility for 
bleed-through effect that indicated the need of sequential imaging. Alexa flour 488 phalloidin 
demonstrated a pass band of 535-590 nm. Figure adapted from Sigma-Aldrich 
documentation. 
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2.3 Cell shrinkage and Ca2+  
 
To measure changes in intracellular calcium ([Ca2+]i) in response to a 
change in osmolarity a FLUOstar OPTIMA plate reader (BMG Labtech, 
Aylesbury, UK) equipped with 320 nm and 520 nm excitation and emission 
lenses, was used. Solutions of varying osmolarity were prepared and media 
osmolarities were measured with VaproTM vapour pressure osmometer, with 
all solutions prepared to ± 5 mOsm. Cells were plated onto a 12 well plate 
(low density), incubated with 2 µM of Fluo-4, 30 min and kept at 37oC for the 
duration of the experiment. Due to the nature of the fluorophore any dye that 
was not specifically associated with the cell surfaces was removed (e.g. 
DMEM has red colour) and the measurements were taken in PBS. Through 
the instrument’s liquid-handling system an osmotic gradient (10-90 %) was 
applied 55 s after the beginning of each recording and subsequently for the 
following 300 s. Data were acquired every 15 s and subsequently transferred 
to Microsoft Excel for analysis. All experiments were performed within 12 h to 
ensure absence of extracellular matrix formation as well as rounded cell 
shape. 
2.4 Molecular biology  
2.4.1 Polymerase chain reaction (PCR) 
2.4.1.1 RNA purification and cDNA conversion 
 
Total RNA was extracted from freshly isolated primary bovine chondrocytes 
using a commercially available kit (Nucleospin RNA II Kit, Macherey-Nagel, 
Düren, Germany). Briefly, according to the manufactures protocol the lysate 
from 5 x 106 cells was filtered and 350 µl of RP1 buffer together containing 
3.5 µl ß-mercaptoethanol (ß-ME) was added to the sample following a 
vigorous homogenisation through a 21-gauge needle (5-10 times) and mixed 
with 350 µl of 70 % ethanol. Samples were then transferred into a 
Nucleospin silica column and RNA allowed to bind to the column and spun 
for 30 s at 11,000 x g using a bench top centrifuge (MiniSpin®, Eppendorf, 
Cambridge, UK). The flow-through was discarded and SPM rDNAsa was 
applied to the reaction mixture thus allowing the elution of highly pure RNA. 
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The flow-through was discarded and column washed with 200 µl RA2 Buffer 
containing guanidine salt. The column was then washed twice with 600 µl 
RA3 buffer and 250 µl of RA3 buffer containing 95 % ethanol to remove 
salts, the membrane was then spun dry to ensure that no liquid remained. 
Elution of RNA was carried out in 40 µl of RNase free water and samples 
kept on ice to be used immediately to make complementary DNA (cDNA).   
 
The RNA concentration was determined by measuring absorbance at 260 
nm by NanoDrop-1000 (Fisher Thermo Scientific, Loughborough, UK) and 
cDNA was synthesized from 1 µg of the total RNA using Improm II Reverse 
Transcription system (Promega, Southampton, UK) according to 
manufactures instructions. Briefly, to ensure denaturation of RNA secondary 
structure, total RNA together with the oligonucleotides were incubated at 70o 
C for 5 min followed by cooling to 4o C for 5 min to insure hybridization. The 
next step was to incubate reaction buffer, MgCl2, dNTPs and Reverse 
Transcriptase (RT) (Table 2.9) 60 min at 42o C at the end of this period RT 
was inactivated at 70o C for 15 min and the template DNA ready for PCR. 
 
 
 
 
 
 
 
 
 
Table 2.9 Target RNA preparation (A) and reverse transcription (B). 
  
COMPONENT VOLUME (µL) 
Nuclease-Free Water (to 
a final volume of 15µl) x 
ImProm-II™5X Reaction 
Buffer 4.0 
MgCl2 (final 
concentration 1.5–8.0 
mM) 
2.0 
dNTP Mix (final 
concentration 0.5 mM 
each dNTP) 
1.0 
Recombinant 
RNasin®Ribonuclease 
Inhibitor  
0.5 
ImProm II™ Reverse 
Transcriptase 1.0 
COMPONENT CONCENTRATION 
Experimental 
RNA 1 µg per reaction 
Random 
primer 0.5 µg per reaction 
Nuclease free 
water x 
(A) (B) 
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2.4.1.2 PCR and Gel electrophoresis  
PCR was performed on the cDNA synthesized by the above protocol; 
GoTaq® Green Master Mix (Promega, Southampton, UK) and the following 
programme were used to synthesize the desired products (Table 2.10 A & B 
and Table 2.11). Cycles of denaturation (at 94o C), annealing and DNA 
synthesis were repeated 35 times.  
 
 
 
Table 2.10 PCR sample preparation (A) and program condition (B). 
 
 
Table 2.11 Primers and products. 
COMPONENT VOLUME (µL) 
GoTaq Green 
Mastemix, 2x 
12.5 
Forward Primer, 10 µl 2.0 
Reverse Primer, 10 µl 2.0 
cDNA Template 2.0 
Nuclease –Free H2O 6.5 
Final Volume 25 
PCR STEP TIME (MIN) 
TEMPERATURE 
(0C) 
Initial 
denaturation 
2 94 
Denaturation     1 95 
Annealing 1 58-62 
Elongation 2 72 
Final 
Elongation 
5 72 
Soak ∞  4 
GENE SEQENCE PRODUCT SIZE 
ANNEALING 
TEMPERATU
RE 
(0C) 
GAPDH 
Forward 
Reverse 
5’-
AGAACGGGAAGCTTGTCATCTC-3’ 
5’-TGAGCTTGACAAAGTGGTCGT-
3’ 
743 bp 58 
COFILIN 
Forward 
Reverse 
5‘-TGGGGTCATCAAAGTGTTCA-3’ 
5’-TTGTCTGGCAGCATCTTGAC-3’ 300 bp 58 
PROFILIN 
Forward 
Reverse 
5'GACTGCCAAGACGCTAGTCC-3’ 
5'-ATGTGTGTGGGAAGGAGAGG-3' 
300 bp 
 62 
GELSOLIN 
Forward 
Reverse 
5‘-TGCAGCTGGATGACTACCTG-3 
5’-GAAGCTCTCCCAGGACACAG-3’ 300 bp 62 
(A) (B) 
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10 µl of the marker (QuickLoad 100 base pairs DNA ladder, New England 
Biolabs, Hitchin, UK) and 25 µl of the PCR samples were loaded onto 2 % 
agarose gel (Fisher Scientific, Loughborough, UK) and run in Tris-Borate-
EDTA buffer (TBE) (Sigma-Aldrich, Poole, UK). The gel was run at 100 V for 
~40 min (5 V/cm) then transferred from the electrophoresis block into a 
solution of ethidium bromide and soaked there for 30 min washed twice with 
water and quantified by the ethidium bromide fluorescence, and analysed 
using ImageJ® software (National Institute of Health, Bethesda, USA). 
2.4.2. Western blot  
2.4.2.1 Cell lysate Preparation 
 
The lysate was prepared from 1 x 106 primary cells that were washed twice 
in phosphate buffered saline (PBS). Cells were lysed with Hot Lysis Buffer 
consisting of 10 % v/v Glycerol (Fisher Scientific, Loughborough, UK), 62.5 
mM Tris-HCL pH6.8 (Fisher Scientific, Loughborough, UK), 2 % sodium 
dodecyl sulphate (SDS) (BDH Biochemical, Poole, UK), 100 mM dithiothreitol 
(DTT) (Sigma-Aldrich, Poole, UK). Proteins were denatured for 5 min at 100 
0C and passed through 25-gauge needle (5-10 times). Extracted proteins 
were then quantified using NanoDrop-1000 (Fisher Thermo Scientific, 
Loughborough, UK).  
2.4.2.2 Sample preparation and SDS-polyacrylamide gel 
electrophoresis (-PAGE)   
 
The same vertical NuPage apparatus (Invitrogen, Paisley, UK) was used for 
electrophoresis and protein blotting. Samples of 50 µg were mixed with 
mixture of 4x Sample Loading Buffer containing ß-ME (5 µl), the volume of 
the sample to be loaded to the gel was determined from the protein 
concentration obtained. 10 µl of Full Range RainbowTM Weight Marker (GE 
Healthcare, Amersham, UK) was added to the first well and samples were 
added to the other wells. The gel was run in 1x running buffer (NuPAGE® 
Running Buffer (20x) diluted with distilled water) at 200 V constant for 50 
min. 
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2.4.2.3 Transfer of protein to nitrocellulose  
Sponges, filter paper and nitrocellulose membrane (Hybond ECL) were 
soaked in 1x blotting transfer buffer (750 ml distilled water, 200 ml Methanol 
and 50 ml NuPAGE® Transfer Buffer (20x)). Once the gel had finished 
running it was removed from the plastic container and the stacking gel was 
cut out. The gel was positioned on the top of the filter paper and the layers in 
the transfer cassette were arranged as follows: 
• Cassette 
• 2x Sponge 
• 2x Filter paper 
• Gel  
• Membrane 
• 2x Filter paper  
• 2x Sponge 
• Cassette cover 
 
All precautions were taken to remove the bubbles that could have appeared 
in the process of the ‘sandwich’ blot preparation. Blotting transfer buffer was 
then poured into the blotting chamber and the chamber was filled with ice 
from outside. Proteins were transferred at 50 V for 90 min. 
2.4.2.4 Protein detection and visualisation 
  
Protein transfer was checked with Ponceau S red stain (0.5 % Ponceau S in 
1 % acetic acid; Sigma-Aldrich, Poole, UK) followed by washing of the 
Ponceau S twice with TBST Buffer (see Appendix). Membranes were 
blocked with 5 % skimmed milk powder in TBST Buffer for 30 min at room 
temperature. Membranes were further incubated for 90 min at room 
temperature (or at 4° C overnight) with either Monoclonal Anti-α-Tubulin 
CloneB-5-1-2 (Sigma-Aldrich, Poole, UK) at 1:2000, P-Cofilin antibody (Cell 
Signalling Technology, Danvers, USA), Cofilin antibody (Cell Signalling 
Technology, Danvers, USA), Profilin-1 antibody (Cell Signalling Technology, 
Danvers, USA) or Gelsolin antibody (Abcam, Cambridge, UK) at 1:2000. 
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After being washed three times for 5 min with TBST buffer, the membranes 
were incubated with an appropriate secondary horse-radish-conjugated anti-
mouse or anti-rabbit antibody (Cell Signalling Technology, Danvers, USA) at 
1:2000 for 45 min on a rocker. Membrane(s) were washed three times for 5 
min, as previously described.  
 
Pierce®ELC Western Blotting Substrate (Fisher Thermo Scientific, 
Loughborough, UK) an enhanced chemiluminescence (ECL) reagent was 
added for 1 min for visualization under red light and then exposed onto film 
for 30 s (Fuji Medical X-ray film, Bedford, UK). The film was exposed to the 
membrane for 30 s. The film was then removed and placed in developer 
(Kodak, Hemel Hempstead, UK) for approximately 3 min before being placed 
in Fixer (Kodak, Hemel Hempstead, UK) for 5 min. The film images were 
scanned to obtain a digital image and the amount of protein in samples and 
was estimated using densitometry analysis. ImageJ®. The intensity of the 
band emission and background emission of the gel and the background was 
subtracted from the intensity of each band. 
2.5 Data Analysis  
 
2.5.1 Viability analysis  
 
To determine cell viability post impact CLSM data was analysed via Imaris 
7.1 (Bitplane, Zurich, Switzerland). In situ chondrocytes demonstrate a wide 
fluorescent range and it was therefore necessary to determine an optimal 
baseline fluorescence threshold (BT) by using Imaris 7.1 calibrated to an 
initial volume obtained from cells in isotonic saline with live cells (green 
spots) and dead cells (red spots; Figure 2.6). The optimal BT for calcein AM 
and PI were, 65 % of the maximum intensity and 15 % of the maximum 
intensity respectively.  
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Figure 2.6 ‘Spot’ analysis optimisation. 
 
A) Cartilage explants were stained with 5 µM Calcein-AM and 1 µM PI to visualise 
live (green) cells and dead (red) cells. Samples were acquired with CLSM. B) 
Visually countable number (counted by eye) of dead cells with spot analysis 
applied. C) Visually countable (counted by eye) number of live cells with spot 
analysis applied. D) Cell number was plotted against threshold percentage and 
linear regression applied. Actual cell number was used to determine the optimal 
threshold percentage to be used with spot analysis. (A) Bar =100 µm (B) Bar = 5 
µm (C) Bar = 10 µm 
 
 
A B 
C 
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2.5.2 Volume analysis   
 
In situ chondrocytes demonstrate a range of fluorescence (Bush et al., 2005) 
therefore, it was necessary to determine optimal fluorescent baseline 
threshold (BT). Briefly, the system was calibrated with fluorescent latex 
beads Fluoresbrite™ (Polyscience Inc., Eppelheim, Germany) of a known 
volume (540 µm3), imaged in the same way as bovine cells and ‘isosurface’ 
applied with spectrum threshold perentage (10-100 %). A linear relationship 
was found between the threshold and the apparent volume with correct 
volume determined at 60 % threshold (Figure 2.7).  
 
Cell volume changes were ascertained by importing the data from Leica SP2 
(Leica Microsystems, Milton Keynes, UK) into Imaris 7.1 (Bitplane, Zurich, 
Switzerland) and application of a feature of the software termed ‘Isosurface’. 
An ‘Isosurface’ was added to each individual cell and the volume calculated, 
Initial images were acquired in control media 280 mOsm for cartilage 
explants and 380 mOsm for isolated chondrocytes. 
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Figure 2.7 Optimization of volume analysis using fluorescent beads with known 
Volume. 
A)    Latex beads overview 
B)   Application of percentage thresholds to a single bead 
Apparent bead volume was used to elucidate the optimal threshold. The percentage     
threshold was plotted against the calculated volume from Imaris and actual bead volume 
was used to elucidate the actual threshold percentage. 
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2.5.3 Actin Analysis   
 
The organization of the actin cytoskeleton was studied using Leica Confocal 
Software LCS Lite (Leica Microsystems, Heidelberg, Germany) by using 
linear profiling across the cell diameter (Kerrigan and Hall, 2005). Briefly, a 
line profile was drown to the centre of each cell perpendicular in the x-y axis 
and parallel in z-axis (Figure 2.8) and then data were exported to Microsoft® 
Excel for further analysis.  
2.5.4 Analysis of changes in calcium 
 
Changes in intracellular calcium were studied using FLUOstar OPTIMA plate 
reader (BMG Labtech, Aylesbury, UK). Through the instrument’s liquid-
handling system osmotic gradient (10-90 %) were applied 55 s after the 
beginning of each recording and followed for 300 s. The gradient for the 
calcium influx curve was calculated to determine the variations in the calcium 
influx in respect to the external osmotic pressure. The gradient of a line in the 
plane containing the x and y axes is generally represented by the letter m, 
and is defined as the change in the y coordinate divided by the 
corresponding change in the x coordinate, between two distinct points on the 
line. This is described by the following equation: 
 
 
 
m=slope 
y= y axe (rise)  
x= x axe (run) 
 
for the purposes of this research the slope was calculated for the Ca2+rise 
until Ca2+ maximum was reached (Figure 2.9).   
  
€ 
m = Δy
Δx =
y2 − y1
x2 − x1
=
rise
run
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Figure 2.9 Slope analyses to determine calcium influx. 
 
Freshly isolated bovine cells were plated on 12 well plates and stained with 2 µM 
Fluo-4, AM for 30 min. Calcium changes were studied using FLUOstar OPTIMA 
plate reader (BMG Labtech, Aylesbury, UK) and the recorded results were 
analysed with slope analysis. Arrow represents when the increased extracellular 
osmolarity was applied and the straight line that is tangent to the curved peak 
represents the function of slope of a curve in the plain.  
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2.6 Data Presentation 
 
All data were expressed as means ± standard error of the mean (s.e.m.), the 
number of explants used within an experiment was given with (N) whilst the 
total number of cells analysed (n) was also given. Graphs were plotted in 
GraphPad PRISM 5 (GraphPad Software, La Jolla, USA). Changes in cell 
volume were calculated using Imaris 7.1 (Bitplane, Zurich, Switzerland). All 
statistical analysis (Student’s unpaired t-tests) and significant differences 
were given as *p< 0.05, **p< 0.01 and ***p< 0.001 and performed using 
Microsoft® Excel 2011 for Mac. 
 
  
 
 
  
 
 
 
  
 
 
 
 
 
 
 
 
 
   (A)       (B)       (C) 
 
            Figure 2.8 Actin Cytoskeleton organization analysed using Liner Profiling Method. 
 
(A) Overview image taken by CLSM. Bovine cells were fixed in 4 % para-formaldehyde and stained with Alexa 488-phalloidin. (B) Actin cytoskeleton 
was studied using Leica Confocal Software LCS Lite, whereby lines were drawn horizontally and vertically across the diameter of each individual cell 
and the fluorescence along the line recorded. (C) Fluorescence profile of a cell recorded along the line. Software LCS Lite, whereby lines were drawn 
horizontally and vertically across the diameter of each individual cell and the fluorescence along the line recorded. (C) Fluorescence profile of a cell 
recorded along the line. 
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3. EXPERIMENTAL CHAPTER: Osmotic Sensitivity of 
Chondrocytes and Chondro-protection in Response to 
Mechanical Trauma. 
 
  
  
  
  
  
  
  
 
 
 
 
 
 
 
CHAPTER 3 
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3.1 Introduction  
 
Whilst mechanical loading is essential for the synthesis and regulation of a 
viable extracellular matrix (ECM), excessive mechanical loading results in 
cartilage damage and formation of tissue lesions or fissures, comprising the 
integrity of the tissue (Verteramo & Seedhom, 2007). Excessive mechanical 
loading on cartilage can be modelled using a drop-tower whereby a pre-defined 
mass is dropped onto a piece of cartilage from a defined height and simulates 
focal impact forces (Aspden et al., 2002). Chondrocytes can be protected from 
the mechanical trauma elicited following drop-tower impact by pre-incubating 
the tissue in hypertonic media, although the exact mechanism of protection is 
unclear (Bush et al., 2005), an increase in extracellular osmolarity leads to a 
decrease in chondrocyte cell volume. When working with chondrocytes it is 
important to note that they behave as perfect osmometers when exposed to a 
hypertonic environment and thus variation in volume can have significant effect 
on their biology and matrix metabolism also known to be influenced by cell 
volume (Urban, 1994, Bush and Hall, 2005, Bush et al., 2005).  
 
Mechanical cartilage trauma is a major concern in high-impact load-bearing 
sport (Kujala et al., 1995, Lequesne, 1997, Saxon, 1999, Roos, 2005, Urquhart 
et al., 2007). Therefore, the elucidation of cartilage damage as a consequence 
of mechanical trauma is of paramount importance for both the casual, 
professional and elite sports person. Chondrocyte death has a major impact on 
the degeneration of articular cartilage depending on strain rate and mechanical 
load (Chen et al., 2001, Bush et al., 2005). Recent studies have proposed that 
chondrocyte viability is intrinsically linked to matrix integrity and high levels of 
cartilage injury results in increased cell death; necrosis and apoptosis (Chen et 
al., 2001, Goldring and Goldring, 2010). In cartilage, it has been shown that 
following a blunt impact there is a ‘wave of chondrocyte death’ that progresses 
further from the impact area (Bush et al., 2005). 
 
Previous studies evaluating impact damage using mechanical models, show 
that one of the key effects on morphology are alterations in cell volume, 
whereby decreasing cell volume leads to a reduction in cell death, thus making 
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them less susceptible to mechanical trauma (Bush et al., 2005, Amin et al., 
2009). Conversely, swelling of in situ chondrocytes by reduced extracellular 
osmolarity, elevates their sensitivity and increases their cell death to 
mechanical loading (Bush and Hall, 2003, Lotz et al., 2004, Bush et al., 2005, 
Grogan and D’Lima, 2010). 
 
3.1.1 Chapter aims 
 
This study aims to expand on the previous work described by investigating:   
 
1) Changes in chondrocyte viability and volume in response to mechanical 
trauma; 
2) Identification of the optimal osmotic challenge for chondro-protection;  
3) The role of extracellular osmolarity in chondro-protection; 
4) The role of actin cytoskeleton in chondro-protection; 
5) To determine the influence of extracellular calcium on chondrocyte 
death.  
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3.2 Results  
3.2.1 Osmotic Sensitivity and Cell Viability in Response to 
Mechanical Trauma  
 
The effects of osmotic sensitivity on cell viability were determined initially by 
investigating cellular response to a gradient of extracellular osmotic challenges. 
Articular cartilage explants were removed from bovine metacarpal/metatarsal 
phalangeal joints and incubated at 37o C with DMEM of 280 mOsm (control), 
380 mOsm, 420 mOsm or 540 mOsm for 1 h, followed by a single impact (see 
section 2.2) and analysed by CLSM for cell volume and cell viability. 
 
Single mechanical impact caused chondrocyte cell death and injury at discrete 
areas on the cartilage explants (Figure 3.1). Step-wise increases in extracellular 
medium osmolarity were utilised to determine the optimal osmotic challenge 
affording chondro-protection within in situ bovine cartilage explants. Cartilage 
explants incubated in 280 mOsm and not subjected to impact showed no 
significant changes in cell viability over the time period thus validating the 
experimental method. Conversely, impacted control samples (280 mOsm), were 
observed to show significant decrease in cell viability (89.69 ± 0.89 %) at 30 min 
post impact (p<0.05). Interestingly, following an increase in extracellular 
osmolarity, a challenge of 280 to 380 mOsm resulted in a 30 % (p<0.001) 
reduction in cell death and a challenge of 280 to 420 mOsm further reduced 
impact-mediated cell death by 50 % (p<0.01) at 30 min post impact (Figure 3.2). 
At 540 mOsm it was noted that present death cell (PDC) was decreased in 
comparison to the control samples but it was not noted to be significantly 
different 30 min post impact (p>0.05) in comparison to control samples with a 
value of 92.07 ± 1.54 % viable cells. 
 
Having determined the effects on different osmotic loads on chondrocyte 
viability (Figure 3.2), the changes on cell volume was subsequently determined. 
Volume in control chondrocytes (i.e. not impacted, 280 mOsm) of in situ 
chondrocytes was 716.14 ± 36.68 µm3 and remained constant throughout the 
30 min period. These data compared favourably to previous published data 
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(Bush et al., 2005, Parker et al., 2010). Cell volume post-impact did not change 
significantly in the control samples, which only decreased by 3 % at 30 min post 
impact (694.18 ± 25.8 µm3, p>0.05). An increase in extracellular osmolarity to 
380 mOsm, 420 mOsm & 520 mOsm led to a significant decrease in 
chondrocyte volume prior to impact (Figure 3.3A), with cell volumes decreased 
by 20 % (578.46 ± 26.85 µm3; p<0.01), 29 % (505.90 ± 21.90  µm3; p<0.001) 
and 39 % (440.13 ± 16.42 µm3; p<0.001) respectively being observed (Figure 
3.3B). Following post mechanical impact no significant changes in cell volume 
were observed 30 min post impact with 561.39 ± 25.55 µm3 (380 mOsm), 
493.12 ± 21.90 µm3 (420 mOsm), 445 ± 18.90 µm3 (540 mOsm) (p>0.05) being 
determined. These data therefore suggest that within the 30 min post impact 
cells have not been significantly altered by the single impact and the initial 
shrinking of the cell volume has protected the cells from the effect of 
mechanical impact. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 
 
 
 
         
 (A)         (B)    (C)    (D)    (E) 
        
 
                     Figure 3.1 Effect of alterations in osmolarity on chondrocyte viability following single mechanical load.  
 
Explants were pre-treated with control isotonic conditions or hypertonic DMEM 380, 420 and 540 mOsm for 1 h and subject to a single 
mechanical load. Samples were loaded with Calcein-AM (5 µM) and PI (1 µM) and images were taken at 30 min post 10 cm impact. (A) non 
impacted cartilage explants in 280 mOsm (B) control sample 30 min post impact (C) sample in hypertonic DMEM 380 mOsm 30 min post impact 
(D) sample in hypertonic DMEM 420 mOsm 30 min post impact (E) sample in hypertonic DMEM 540 mOsm 30 min post impact. Bar = 100 µm. 
Images for all panel (A-E) were acquired by axial confocal laser scanning microscopy (CLSM) projections imaging the superficial zone of 
cartilage ‘top-down’ from the articular surface. 
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Figure 3.2 Chondro-protective role of hyperosmotic pre-treatment on cell viability 
following single mechanical load.  
Explants were pre-treated with control isotonic conditions or hypertonic DMEM 380, 420 and 
540 mOsm for 1 h and subject to a single mechanical load. Samples were loaded with 
Calcein-AM (5 µM) and PI (1 µM) and images were taken at 2, 5, 10, 20 & 30 min post 
impact. Data are mean +/- SEM of N=9, *p<0.05, **p<0.01, ***p<0.001 all vs. control (280 
mOsm). 
 
 
 
 
      
 
 
 
 
 
 
Table 3.1 Role of hyperosmotic pre-treatment on cell viability following single 
mechanical load.  
 
Osmolarity 
(mOsm) 
Viability at 2 min 
(%) 
Viability at 30 min 
(%) 
No Impact 
280 98.00 ± 0.30 97.35 ± 0.20 
Control 
(280) 96.03 ± 0.30 89.69 ± 0.89 
380 97.68 ± 0.32*     95.50 ± 0.54*** 
420 97.03 ± 0.29*    94.39 ± 0.34 ** 
540  97.10 ± 0.30 92.07 ± 1.54 
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Figure 3.3 Hyperosmotic pre-treatment decreases chondrocyte cell volume post 
mechanical trauma. 
Cartilage explants were pre-treated for 1 h with control isotonic or hypertonic DMEM of 380, 
420 and 540 mOsm that represented 30 %, 50 % and 90 % increase of extracellular 
osmolarity respectively and subject to a single mechanical load. Samples visualised by 
CLSM were loaded with Calcein-AM (5 µM) and PI (1 µM) and images were taken 30 min 
post impact (A). Isosurface volume analysis were used to quantify cell volume and to 
quantify cell viability, spot analysis method was employed. Data are mean +/- SEM of N=9 
n=60 from 3 distinct experiments (B) and N=9 from 3 distinct experiments (C). *p<0.05, 
**p<0.01, ***p<0.001 all vs. control (280 mOsm). 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3.2 The effect of hyperosmotic pre-treatment on chondrocyte cell volume and 
viability post mechanical trauma. 
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3.2.2 Effects of medium osmolarity on calcium signalling  
 
The biophysical mechanisms of mechanical signal transduction are not fully 
understood but are believed to involve changes in osmolarity (Pritchard et al., 
2002). The chondrocyte plasma cell membrane is relatively permeable and 
increasing extracellular osmolarity leads to decrease of cell volume (Kerrigan 
et al., 2006). Alteration of cell volume is responsible for triggering volume 
recovery mechanisms that involve activation of ion channels and intracellular 
signalling cascades in an effort to restore cell volume (O’Neil, 1999, Amin et 
al., 2008). In particular, intracellular calcium [Ca2+]i represents an ubiquitous 
signalling mechanism and is involved in processes as diverse as cell division 
and apoptosis (Berrige et al., 1998, Roberts et al., 2001). Cells utilise two 
sources of Ca2+ for the generation of signals: Ca2+ released from the 
intracellular stores and activation of plasma membrane ion channels resulting 
in Ca2+ entry (Wilkins et al., 2000). Ca2+ signals can be modulated in space 
and time and this influences [Ca2+]i concentration, thereby suggesting  Ca2+ 
signalling plays an important role in regulatory volume control and is a 
mediator in mechanotransdution (Amin et al., 2008, Kerrigan and Hall, 2008). 
 
The series of experiments demonstrated that replacement of the control 
solution with identical solution resulted in no significant changes of [Ca2+]i 
however, replacement of the isotonic solution with hyperosmotic solution 
caused an increase spike of [Ca2+]i. Therefore, it was important to determine 
the behaviour of [Ca2+]i in relation to different osmotic gradients in order to 
understand the level of protection offered by increased osmolarity. To closely 
monitor the volume regulatory behaviour a number of hyperosmotic 
challenges were used, where medium osmolarity was altered by 10, 20, 30, 
40, 50, 60 & 90 %. From the raw data recorded a significant increase of 
calcium approximately a 10 % was observed in response to 10% osmotic 
change, 20 % and 30 % increased osmolarity (Figure 3.6) compared to only 
approximately 5 % or less for 40%, 50%, 60%, and 90% hyperosmotic 
challenges (Figure 3.4).  
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Having determined the percentage increase in intracellular calcium, the rate 
of the changes was then calculated. The gradient analysis (see Materials and 
Methods, Section 2.5.4) was used to allow for a better investigation and 
understanding of the effect of increased osmolarity on freshly isolated cells. 
Chondrocytes perfused with low hypertonic challenges (420 mOsm & 460 
mOsm), exhibited increase in Ca2+ by 0.58 ± 0.01 and 0.57 ± 0.03 relatively 
(Figure 3.5), acute hypertonic challenges above 30 % (540 mOsm, 570 
mOsm, 720 mOsm) did not significantly increase rate in Ca2+ thus showing 
that calcium changes are not respectively related to cell shrinkage and 
suggesting that additional mechanisms are involved in volume regulatory 
changes. 
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Figure 3.4 Representative traces of extracellular calcium changes in response to 
hyperosmotic stress in freshly isolated chondrocytes (Po).  
 
Freshly isolated bovine articular chondrocytes in 380 mOsm control saline were incubated 
with fluo-4 AM (2 µM, 30 min, 37o C) for the measurement of [Ca2+]i. The initial resting 
intensity was recorded for 55 s in an isotonic saline (380 mOsm) and then a hyper osmotic 
challenge (420 mOsm; 10 %, 460 mOsm; 20%, 500 mOsm; 30 %, 570 mOsm; 50 %, 610 
mOsm; 60 %, 720 mOsm; 90 %) was applied shown by arrow. For intracellular Ca2+ 
measurements, fluorescence emissions at 516 nm was measured and data is shown in 
percentage of n=6 samples from 3 distinct experiments. 
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Figure 3.5 Changes in Ca2+ following addition of hyper osmotic gradient. 
 
Freshly isolated bovine cells were plated on 12 well plates and stained with 2 µM 
Fluo-4, AM for 30 min. Calcium changes were studied using FLUOstar OPTIMA 
plate reader (BMG Labtech, Aylesbury, UK) and the recorded results were 
analysed with slope analysis. Panel (A) Arrow represents when the increased 
extracellular osmolarity was applied. Max rise ration determined by slope analysis. 
Data are mean +/- SEM of n=6 samples *p<0.05, **p<0.01, ***p<0.001 all vs. 
control.  
Osmolarity 
Gradient 
change (%) 
Initial rate of change 
m=rise/run (fluorescence/time-s) 
Control  0.15 ± 0.01 
10  0.58 ± 0.01 * 
20   0.57 ± 0.03 * 
30 0.33 ± 0.06 
40 0.38 ± 0.08 
50 0.18 ± 0.01 
60 0.20 ± 0.01 
90 0.40 ± 0.01 
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3.2.3 Extracellular calcium and its role in chondrocyte death in 
response to Mechanical Trauma  
 
Changes in calcium have been implicated in cell volume regulation (Erickson 
et al., 2003, Kerrigan and Hall, 2008, Amin et al., 2008, Pritchard et al., 2008) 
and in chondrocyte death associated with mechanical injury (Amin et al., 
2009, Huser and Davies, 2007) and importantly play a role in many aspects 
of mechanotransduction (Kerrigan et al., 2006, Amin et al., 2009, Han et al., 
2012). Here the effect of extracellular calcium and any potential calcium 
influx on chondrocyte death following mechanical injury was determined in 
bovine explants incubated with EGTA (2 mM), thus removing extracellular 
calcium (Kerrigan and Hall, 2005). 
 
Bovine cartilage explants were incubated in control DMEM (280 mOsm), 
EGTA (2 mM; 280 mOsm) and EGTA (2 mM) with increased osmolarity 380 
mOsm and subjected to impact by drop tower. Post mechanical trauma, cell 
death was not significantly altered in samples with 10.34 ± 0.77 % (control), 
10.95 ± 0.62 % (EGTA) and 9.73 ± 0.62 % (EGTA 380 mOsm) PDC 
respectively over 30 min (Figure 3.6A).  
 
Having determined the changes in chondrocyte viability following impact 
changes in cell volume were then investigated. Significant changes in cell 
volume were observed in in situ chondrocytes, whereby the cell volume of 
chondrocytes recorded in the presence of 280 mOsm EGTA decreased from 
716.14 ± 36.68 µm3 in control samples to 600.32 ± 18.33 µm3 (p<0.05) and 
486.40 ± 20.33 µm3 (p<0.001) for in situ chondrocytes incubated in 380 
mOsm EGTA. Data suggesting that the extracellular calcium might play a 
role in the later stages post-mechanical injury but not within the first 30 min 
(Figure 3.6B). These data also suggests that shrinkage and the presence of 
calcium are both important factors in chondro-protection. 
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Figure 3.6 Short-term chondrocyte response to mechanical trauma and the role of 
calcium influx. 
 
Bovine cartilage explants were pre-treated with control isotonic DMEM, EGTA supplemented 
(2 mM) and hypertonic (380 mOsm) EGTA (2 mM) supplemented BPS for 1 h and subject to 
single mechanical load. (A) Samples were loaded with Calcein-AM (5 µM) and PI (1 µM) and 
images were taken at 2, 5, 10, 20 & 30 min post impact with CLSM. To quantify cell viability 
Imaris Spot analysis was used N=12 from 3 distinct experiments. Arrow denotes impact 
point. (B) Samples were stained with Calcein-AM (5 µM) and analysed at 30 min with Imaris 
Isosurface to quantify cell volume. Data are mean +/- SEM of N=9 and n=50 from 3 distinct 
experiments. *p<0.05, **p<0.01, ***p<0.001 all vs. control.  
(B) 
(A) 
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As the previous data (see section 3.2.2) suggested role for a calcium influx in 
the mechanism of cell death, the effect on cell shrinkage on chondro-
protection and the role of stretch activated calcium channel (SACC) was then 
determined. Non-impacted cartilage pre-incubated with 100 µM GdCl3 was 
evaluated for chondrocyte viability. No differences were observed between 
treated and un-treated non-impacted explants therefore providing confidence 
that any changes in chondrocyte death post impact were related to the effect 
of GdCl3 on SACC. GdCl3 treated cartilage explants were subjected to 10 cm 
impact and cell viability determined, in control (280 mOsm) DMEM, 3.97 ± 
0.30 % of cells were non-viable at 2 min post impact and cell death was 
increased to 10.31 ± 0.89 % at 30 min. The addition of hypertonic challenge, 
reduced the initial cell death to 2.18 ± 0.18 % (p>0.05) compared to control 
samples. Conversely, at 5, 10, 20 & 30 min post impact PDC for cells 
incubated in hypertonic soluion was observed to be significantly different 
from the control sample with PDC recorded to be 3.97 ± 0.30 %, measured at 
30 min post-impact with 6% decrease in cell viability (p<0.001; Figure 3.7). In 
contrast, incubation with GdCl3 reversed this protective effect causing a 
significant increase in cell death such that at 2 min, 10.67 ± 1.12 % (p<0.001) 
cells were dead which increased to 20.45 ± 3.88 % non-viable cells at 30 min 
post-impact (p<0.01).  
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Figure 3.7 The effect of cell shrinkage and gadolinium chloride on chondrocyte 
viability following single impact.  
 
Cartilage explants were incubated in control and hypertonic DMEM (380 mOsm) with and 
without the presence of 100 µM GdCl3. Explants were then subjected to a 10 cm impact and 
viability determined by Imaris spot analysis. Samples visualised by axial confocal laser 
scanning microscopy (CLSM) projections imaging the superficial zone of cartilage ‘top-down’ 
from the articular surface were loaded with Calcein-AM (5 µM) and PI (1 µM). Images: (A) 
not impacted sample (B) Control taken after 30 min post impact (C) hypertonic DMEM taken 
after 30 min post impact (D) hypertonic DMEM with presence of GdCl3 taken after 30 min 
post impact. (E) A pre-incubation in a hypertonic DMEM protected chondrocytes from impact 
trauma by significantly preventing cell death. Conversely, the addition of GdCl3 reversed and 
increased cell death following impact. Data are mean +/- SEM of N=9 from three distinct 
experiment *p<0.05, **p<0.01, ***p<0.001 all vs. control. Arrow denotes impact point. Bar = 
300 µm.  
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3.2.4 The role of F-actin cytoskeleton on chondrocyte death in 
response to Mechanical Trauma. 
 
Previous studies have shown that remodelling the actin cytoskeleton plays a 
vital role in maintaining cell structure and integrity of bovine articular 
chondrocytes as well as being an important step of the cellular response to 
osmotic stress (Gulilak et al., 1995, Erickson et al., 2003, Blain, 2009). Of 
relevance it has also been shown that changes in calcium can trigger 
changes in F-actin and that F-actin may serve as store of Ca2+ (Pritchard et 
al., 2002). In addition, filamentous actin organisation has been noted to be 
less defined in OA suggesting a defective function of F-actin in OA (Blain, 
2009).   
 
To investigate this, bovine explants were incubated for 1 h with Lantranculin 
B (10 µM), an inhibitor of actin polymerisation (Kerrigan and Hall, 2005). 
Latrunculin B caused a significant increase in cell death at 30 min post 
mechanical trauma with 15.0 ± 0.78 %, (5 %; p>0.001) cell death being 
observed, no significant differences were observed within the first 2-20 min 
post impact (2-20 min; p<0.05). In contrast, when Jasplakinolide (5 µM) a 
stabilizer of F-actin (Bubb et al., 2000) was added, cell viability was 
increased with only a modest percentage of dead cells being observed at the 
initial stages post mechanical injury (10 min) of 3.35 ± 0.30 % (p<0.01) and 
at 30 min post impact a cell death value of 4.84 ± 0.46 % (p<0.001; Figure 
3.8). Thus confirming that F-actin cytoskeleton plays an important role in the 
chondro-protective mechanisms. Interestingly, PDC data recorded for 
cartilage explants incubated in Jasplakinolide was very similar to data 
recorded for cells incubated in hyperosmotic (380/420 mOsm) DMEM post 
impact hence implicating the role of F-actin cytoskeleton. 
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Figure 3.8 The effect of F-actin opposing agents Latrunculin B and Jasplakinolide on 
chondrocyte viability following single impact.  
 
Cartilage explants were incubated in control isotonic DMEM (280 mOsm), Latrunculin B (10 
µM) or Jasplakinolide (5 µM) supplemented DMEM and then subjected to 10 cm impact.  
Images were taken by CLSM at 2, 5, 10, 20 & 30 min post impact and cell viability quantified 
via Imaris spot analysis. Data are mean +/- SEM of N=9 from 3 distinct experiments. Arrow 
denotes impact point. *p<0.05, **p<0.01, ***p<0.001 all vs. control.    
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3.2.5 Organisation of the polymerised actin cytoskeleton and their 
response to hyperosmotic and calcium changes within in situ and 
freshly isolated chondrocytes (Po) 
 
The effect of the actin cytoskeleton has been implicated to play a vital role in 
maintaining cell structure and integrity in different studies (Gulilak et al., 
1995, Erickson et al., 2003, Trickey et al., 2004, Pritchard et al., 2008, Blain, 
2009) within the previous section it was shown that F-actin re-modelling 
agents can offer or remove protection in regards to single impact loads. The 
role of F-actin cytoskeleton and the effect of the hypertonic and calcium 
changes were then investigated using linear profiling (see Materials & 
Methods, section 2.5.3). In both in situ and freshly isolated bovine 
chondrocytes F-actin appeared punctate, within in situ chondrocytes, it was 
presented in all zones, however at significantly higher concentrations within 
the SZ (65.43 ± 3.49 AU; p<0.01) compared to the MZ and DZ. No significant 
differences were found between the MZ 56.49 ± 6.36 AU and DZ 53.10 ± 
0.21 AU (p>0.05; Figure 3.9) 
 
An increase in extracellular osmolarity (280-380 mOsm) resulted in a 
significant increase in cortical actin concentration (p<0.05) for the SZ (84.79 
± 2.36 AU) but remained unchanged for both the MZ and DZ with 60.81 ± 
7.85 AU and 52.80 ± 3.45 AU respectively, in the relative concentration of 
cortical actin (Figure 3.10). Following a 1 h pre-incubation with GdCl3 there 
was a significant (p<0.01) inhibition of actin polymerisation in the SZ (44.89 ± 
0.85 AU) and interestingly a 30 % decrease in cortical actin labelling for both 
MZ and DZ (p<0.05/p<0.05). Interestingly, pre-incubation with 2 mM EGTA 
(chelator for Ca2+) prevented the hypertonic induced F-actin rise for the SZ 
cells (70.75 ± 2.36 AU (p<0.01)). Whilst in the MZ and DZ there was a 
reduction in the overall concentration of cortical actin to 44.01 ± 4.69 AU 
(p<0.01) with a more profound effect in the DZ 37.41 ± 1.38 AU (p<0.05). 
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Figure 3.9 Actin organisation within in situ bovine articular cartilage as determined by 
Confocal Laser Scanning Microscopy.  
 
To determine the role of the actin cytoskeleton in chondro-protection cartilage explants were 
incubated in control 280 mOsm DMEM, fixed and the polymerised actin cytoskeleton 
labelled with Alexa 488-phalloidin. Images were acquired by coronal CLSM projection of 
cartilage and deconvolved (by specialist software). Panel (A) shows the discrepancies within 
the cell shape of chondrocytes. Images were aquired transversely to the articular surface. 
Bar = 5 µm Panel (B) Shows the increase in polymerisation of the actin cytoskeleton in the 
SZ. Data are mean +/- SEM of N=9, n=30 *p<0.05, **p<0.01, ***p<0.001 all vs. SZ cells.  
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Figure 3.10 The role of the actin organization in chondrocyte protection. 
 
Cartilage explants were incubated in control and hypertonic DMEM (380 mOsm; 30 %) with 
and without the presence of 100 µM GdCl3 or 2 mM EGTA. Explants were fixed with 4 % 
paraformaldehyde and the polymerised actin cytoskeleton labelled with Alexa 488-phalloidin. 
Linear profiling analysis was used to quantify F-actin. Data are mean +/- SEM of N=9 n=30, 
*p<0.05, **p<0.01, ***p<0.001 all vs. control.    
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To further investigate the role of the actin cytoskeleton, in a separate series 
of experiments the above agents were used to observe the effect of changes 
on the F-actin cytoskeleton within freshly isolated bovine articular 
chondrocytes (Po). The results recorded resembled the behaviour of in situ 
chondrocytes within the SZ. With an increase of extracellular osmolarity by 
30 % the polymerisation of the F-actin cytoskeleton significantly increased to 
64.39 ± 9.39 AU (p<0.001) compared to control samples 51.68 ± 7.89 AU. 
Interestingly, increasing the extracellular osmolarity by 50 % and 90 % did 
not significantly increase the levels of F-actin compared to 30 % with values 
62.80 ± 9.39 AU and 67.33 ± 9.80 AU respectively (p>0.05). These data 
therefore suggest that altering the extracellular osmolarity by 30 % is 
sufficient to re-model F-actin cytoskeleton in freshly isolated cells (Figure 
3.11).  
 
The addition of GdCl3 and EGTA to freshly isolated cells (Figure 3.12) was 
recorded and in the presence of EGTA, 25 % of the cells exhibited increase 
in cortical actin (p<0.001) compared to control Po cells. The addition of 
increased extracellular osmolarity in EGTA treated cells did not change the 
results recorded and data recorded was not significantly different from EGTA 
only treated cells with value of 68.02 ± 9.51 AU. GdCl3 treatment inhibited the 
cortical actin concentration with a 15 % (p<0.001) reduction in freshly 
isolated cells compared to in situ chondrocytes thus showing a similar 
behaviour to data accrued from cartilage explants (Figure 3.10). However, it 
should be noted that isolated cells behaved differently in presence of EGTA 
or when incubated in the presence of EGTA and hypertonic conditions 
(p<0.05) thus suggesting that the ECM may be slowing down the effects of 
EGTA for in situ explants (Figure 3.12). 
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Figure 3.11 F-Actin organisation and the effect of Hyperosmotic pre-treatment on 
freshly isolated chondrocytes (Po).  
 
Freshly isolated cells (Po) were pre-treated for 1 h with control isotonic DMEM of 380 
mOsm, or hypertonic DMEM of 500, 570 and 720 mOsm that represented 30 %, 50 % and 
90 % increase of extracellular osmolarity respectively. Cells were fixed with 4 % 
paraformaldehyde and the polymerised actin cytoskeleton labelled with Alexa 488-phalloidin. 
Linear profiling analysis was used to quantify F-actin. Data are mean +/- SEM of n=30, 
*p<0.05, **p<0.01, ***p<0.001 all vs. control from three distinct experiments.  
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Figure 3.12 The role of actin organisation and the effect of cell shrinkage, gadolinium 
chloride and EGTA on freshly isolated chondrocytes (Po). 
 
Freshly isolated cells (Po) were pre-treated for 1 h in control and hypertonic DMEM (380 
mOsm; 30 %) with and without the presence of 100 µM GdCl3 or 2 mM EGTA, fixed with 4 % 
paraformaldehyde. The polymerised actin cytoskeleton labelled with Alexa 488-phalloidin. 
Linear profiling analysis was used to quantify F-actin and following a hypertonic challenge. 
Data are mean +/- SEM of n=30, *p<0.05, **p<0.01, ***p<0.001 all vs. control from three 
distinct experiments.  
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3.3 Summary  
 
Mechanical loading following a single impact caused a rapid initial cell death 
followed by a slower subsequent death within a short period of time (30 min). 
Single mechanical load on some occasions caused fissures within the 
cartilage explants thus compromising the integrity of the tissue. Formations 
of tissue lesions or fissures that compromise the integrity of tissue have been 
reported to increase the risk of development of secondary OA (Bader et al., 
2011, Goldring, 2012). Cell shrinkage following a hypertonic challenge of the 
medium reduced the rates of cell death in chondrocytes, post-mechanical 
impact and offered chondro-protective effect. Furthermore, hypertonic 
treatment resulted in an increase in F-actin polymerisation prior to impact 
and protected against cell death. 
 
Interestingly, removal of extracellular calcium with EGTA was not shown to 
be chondro-protective (Amin et al., 2009) within the first 30 min post impact, 
however in situ chondrocytes showed characteristics related with chondro-
protection such as reduction of cell volume thus indicating that calcium influx 
might have a time-delayed effect. Treatment with GdCl3 which blocks [Ca2+]i 
(Erickson et al., 2001, Lewis et al., 2011) led to an exacerbation in cell death, 
even when the chondro-protective challenge was employed, thus indicating 
that the stretch-sensitive calcium channels were involved in affording 
chondro-protection. Potential explanations for this effect could be due to 
Young’s Modules or perhaps channel activation.  
 
Treatment of cells with Jasplakinolide (the F-actin stabilising agent) resulted 
in chondro-protection, indicating a role for F-actin, whilst Latrunculin B (the 
actin depolymerising agent) increased cell death, again drawing attention to 
the cell cytoskeleton and its role in chondro-protection. 
 
Finally, the organisation of the actin cytoskeleton was evaluated and was 
observed that in situ and isolated cells respond in similar way to 
environmental changes. Additionally, it was observed that cells within 
characteristically different cartilage zones responded differently to 
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environmental changes. The increase in extracellular osmolarity, and thus 
chondro-protection following impact load, was the result of a polymerisation 
of the actin cytoskeleton that was dominant in the SZ zone alone and was 
inhibited by a pre-incubation with the stretch-sensitive calcium channel 
inhibitor GdCl3.  
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4. EXPERIMENTAL CHAPTER: REV5901 and 
isomers; and investigation of its Chondro-protective 
Actions. 
 
 
 
CHAPTER 4 
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4.1 Introduction  
 
Whilst mechanical loading is recognised to be important and essential for 
maintaining healthy cartilage and a viable ECM (Wilkins, 2000, Kruz et al., 
2005), repetitive and excessive mechanical loading can cause hydrostatic 
stress, tensile strain and abnormal fluid shear stress leading to irreversible 
cartilage erosion and acute traumatic joint injury, recapitulating the hallmarks 
of OA (Felson et al., 2000, Buckwalter et al., 2006). As shown in Chapter 3, a 
blunt mechanical trauma led to a rapid cell death and a decrease in cortical 
actin. Previous studies have reported that injured cartilage has a limited 
capacity for repair and several studies have shown that excessive 
mechanical loading can trigger apoptosis and necrosis in chondrocytes as 
well as causing structural damage to cartilage (Borelli et al., 1997, Jeffrey et 
al., 1997, Chen et al., 2001, D’Lima et al., 2001a, Kurz et al., 2001, Amin et 
al., 2008). 
 
Osteoarthritis (OA) is a degenerative disease marked by destruction of 
cartilage with multifactorial causes, but is generally strongly associated with 
age and mechanical aspects (Felson et al., 2000, Buckwalter and Martin, 
2004). Different studies have examined both the biochemical and 
morphological nature of the disease and shown a possible ‘pre-osteoarthritic 
state’ in relation to the mechanism of joint damage with overuse (Vasan, 
1983, Brown et al., 1984, Lequesne et al., 1997, Buckwalter and Martin 
2004, Felson and Kim, 2007). Mechanical impact or joint overuse has been 
reported to be responsible for cartilage fissures and lesions (Donohue et al., 
1983) and evidence exists that high impact sports e.g. football, show an 
increased risk of OA in knee and hip joints (Lindberg et al., 1993, Roos et al., 
1994, Urquhart et al., 2007, Dvorak, 2011). It is therefore important to 
investigate the protective mechanisms against mechanical loading and 
supplements that may afford chondro-protection as current treatments mainly 
target symptoms of the pathology e.g. pain. Recent studies have reported 
increased evidence in the role of the subchondral bone in OA, thus both 
articular cartilage and the subchondral bone are considered to be involved in 
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the initiation and progression of this pathology (Spector et al., 2005, Iwamoto 
et al., 2010). This has resulted in the interest of drugs that influence bone 
metabolism such as the promising chondro-protective agent pyridinyl 
bisphosphonate risedronate approved for clinical use since 2000 in the USA, 
for the treatment of osteoporosis (Van Offel et al., 2005, Mauck and Clarke, 
2006), and the tetracycline antibiotic doxycycline which has been shown to 
inhibit cartilage MMPs (Smith et al., 1996, Shilopov et al., 1999). However, 
neither has been associated with definitive results and effectiveness has 
been questioned due to large heterogeneity between studies (Nüesch et al., 
2009, Da Costa et al., 2012). In addition to this, some safety concerns have 
been raised with the long-term use of doxycycline (Dieppe, 2005, Da Costa 
et al., 2012). Therefore, the need to identify novel chondro-protective agents 
is paramount and in this study, the RVD inhibitors, REV 5901 and L-665, 238 
(REV 5901 para-isomer) have been investigated for their potential role to 
uncover a chondro-protective pathway. 
4.1.1 Chondro-protective agents 
 
REV 5901 (a-pentyl-3-(2-quinolinylmethoxy)-benzene-methanol is a 5-
lipoxygenase inhibitor (McMillan and Walker, 1992, Bush and Hall, 2001), an 
antagonist of a family of G-protein coupled receptors (the cystenyl-
leukotriene receptors; CYS-LT) in porcine epithelial cells (Van Inwegen et al., 
1987) and an inhibitor of RVD (Hall et al., 1998, Qusous et al., 2012). Since 
targeting volume changes that have been reported to be important for 
chondro-protection (Clark et al., 2010), the effect of REV 5901 was 
investigated as a potential novel therapeutic chondro-protective agent. 
  
The para-isomer of REV5901 (L-655,238) was also investigated and is a 
potent and selective inhibitor of 5-lipoxygenase activating protein (FLAP; 
Evans et al., 1991). However, despite the similarity with REV 5901, L-
655,238 has reported differing results regarding its efficacy, with studies 
highlighting that although its a potent and selective inhibitor of FLAP (Ford-
Hutchinson, 1991), it does not exhibit the same range of properties as REV 
5901 and thus its effects were investigated here. 
RESULTS'' 87 
 
  
 
 
4.1.2 Chapter aims 
 
This study aims to investigate the chondro-protective properties of a panel of 
pharmacological compounds determining their effects on: 
 
1. Short term post- mechanical impact on chondrocyte viability and volume; 
2. Short term post-mechanical trauma;  
3. Investigation of the involvement of a known pathway in the potential 
mechanism of chondro-protection; 
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4.2 Results  
4.2.1 REV 5901: the protective effect on bovine articular cartilage 
following mechanical impact.  
 
After confirming the initial osmolarity of DMEM using a VaproTM pressure 
osmometer to be 280.71 ± 0.70 mOsm, the osmolarity of DMEM with the 
addition of REV 5901 and DMSO (vehicle for REV 5901) was determined 
with an osmolarity of 281.00 ± 0.70 mOsm and 281.14 ± 1.76 mOsm 
respectively observed, non-significant compared to DMEM osmolarity alone 
(Figure 4.1). 
 
Following identification that medium osmolarity was not altered by addition of 
DMSO (drug vehicle), the effects on cell volume and viability were 
investigated, using Imaris 7.1 ‘Iso surface’ or ‘Spots’ as previously described  
(Bush et al., 2005, Kerrigan et al., 2005, Nedelcheva et al., 2008). Following 
addition of REV 5901, cell volume changed significantly compared to control 
isotonic conditions (280 mOsm) decreasing from 716.14 ± 36.68 µm3 to 
552.68 ± 24.38 µm3 (p<0.001) respectively, with a decrease of 23 %. These 
data show similar trends to volume changes recorded for in situ 
chondrocytes incubated in hypertonic conditions (380 mOsm) observed in 
chapter 3, 578.46 ± 26.85 µm3 (p>0.05; Figure 4.2).  
 
Following identification of the effects on cell volume, the effects of REV 5901 
on cell viability were subsequently investigated. REV 5901 treatment 
displayed no detrimental effect on chondrocytes or cartilage. Explants pre-
treated for 1 h with REV 5901 (50 µM) have experienced a reduction in PDC 
by 51 % to 5.44 ± 0.59 % (p<0.001) compared to the control sample where 
impact led to an 11.23 ± 1.24 % cell death 30 min post impact. When cell 
death was examined in samples treated only with vehicle (DMSO, 0.1 %) 
loss of cell viability 30 min post impact was recorded as 9.20 ± 0.65 % 
(p>0.05), compared to control samples (Figure 4.3) thus indicating that 
DMSO cannot be responsible for the increased cell viability of cells treated 
with REV 5901. 
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Figure 4.1 REV 5901 has no effect on medium osmolarity.  
 
Using VaproTM vapour pressure osmometer samples of control isotonic DMEM, DMSO (0.1 
%) and REV 5901 (50 µM) supplemented DMEM were measured for osmolarity. The 
addition of nether DMSO or REV 5901 was observed to significantly alter medium 
osmolarity. N=20  
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Figure 4.2 REV 5901 decreases cell volume.   
 
Bovine articular cartilage explants were pre-treated for 1 h with control isotonic, hypertonic 
(380 mOsm) DMEM or DMSO (0.1 %) or REV 5901 (50 µM) supplemented DMEM. Samples 
were loaded with Calcein AM (5 µM) and images were acquired with CLSM post treatment 
(A) using a x63 dipping objective imaging ‘top-down’ from the articular surface. To quantify 
cell volume ‘Iso surface’ volume analyses were used and REV 5901 was observed to 
significantly decrease cell volume (B). N=9, n=40 cells, *p<0.05, **p<0.01, ***p<0.001 all vs. 
control from three distinct experiments. Bar in (A) = 5 µm 
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Figure 4.3 Pre-treatment with REV 5901 protects against cell death post impact. 
 
Bovine articular cartilage explants were pre-treated for 1 h with control isotonic, hypertonic 
(380 mOsm) DMEM, DMSO (0.1 %) or REV 5901 (50 µM) supplemented DMEM. Samples 
were loaded with Calcein AM (5 µM) and PI (2 µM) subject to single impact (10 cm) and 
images were acquired with CLSM prior and post impact at 2, 5, 10, 20 and 30 min. To 
quantify cell death Imaris spot analysis were used. REV 5901 was observed to protect 
against cell death.  N=9, n=27 explants,  *p<0.05, **p<0.01, ***p<0.001 all vs. control from 
three distinct experiments. Arrow denotes impact point. 
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Condition 
Viability at 2 min 
(%) 
Viability at 30min 
(%) 
Control (280) 95.86 ± 0.27 89.08 ± 1.02 
DMSO 97.18 ± 0.27 90.08 ± 0.35 
REV 5901 97.45 ± 0.39 94.56 ± 0.59 *** 
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4.2.2 The effect of the L-655,238 (REV 5901 para-isomer) on 
articular cartilage explant cells. 
 
The potent and selective inhibitor of FLAP, L-655,238 (REV 5901, para-
isomer) was used in order to help identify whether the isomer or the active 
form would be a more potent inhibitor of chondrocyte cell death. The 
osmolarity of L-665,238 supplemented DMEM was investigated to rule out 
the possibility that its effects were via osmotic mechanisms where DMSO 
was used as a vehicle. L-665,238 did not significantly alter the osmolarity 
medium with osmorarity of 280.86 ± 1.68 mOsm compared to control DMEM 
and DMSO supplemented medium, 280.71 ± 0.70 mOsm and 281.14 ± 1.76 
mOsm respectively (Figure 4.4).  
 
Cell shrinkage has previously been determined to be chondro-protective 
(Bush et al., 2005, Lewis et al., 2007) and treatment of cartilage explants with 
REV 5901 (50 µM) caused this (Figure 4.3), given this observation the effect 
of L-655,238 was determined. L-655,238 (50 µM) significantly decreased cell 
volume from 716.14 ± 36.68 µm3 in control samples to 513.54 ± 23.15 µm3 a 
reduction of 28% (p<0.001). When compared to the shrinkage caused by 
REV 5901 (552 ± 24.38 µm3) it was found that this reduction of in situ 
chondrocyte cell volume was similar to that observed with REV 5901 
treatment (p>0.05). DMSO supplemented DMEM used as a control caused 
an increase in cell volume and thus the effects of the drug were not due to 
the vehicle used hence, data was consistent with our previous findings 
(Figure 4.5). 
 
Following a 10 cm impact delivered by a drop tower, chondrocyte death in 
explants incubated with L-655,238 supplemented DMEM conveyed an 
interesting pattern. Results recorded for the first 15 min were similar to 
DMSO and REV 5901 incubated samples with no significant differences in 
cell death for chondrocytes incubated in L-655,238 compared to control 
samples. Twenty min post impact data for L-655,238 incubated samples 
showed a similar response to REV 5901 incubated explants and were 
significantly different from control 4.95 ± 0.51 and 4.87 ± 0.53, p<0.01 
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respectively. Lastly 30 min post impact PDC was recorded to be 7.31 ± 0.59 
% in L-655,238 treated cells compared to control samples where PDC was 
10.92 ± 1.02 % thus showing a significant reduction (p<0.05). Interestingly, 
when comparing REV 5901 to L-655,238 it was found that REV 5901 
demonstrated a greater chondro-protective effect. Significantly decreasing 
cell death by 51 % (p<0.001) at 30 min post impact compared to only 5 % 
(p<0.05) for L-655,238 at 30 min post impact with protective effect 
diminishing over time (Figure 4.6 A & B), thus suggesting that L-655,238 
does not possess the chondro-protective potential seen by REV 5901.  
  
RESULTS'' 94 
 
  
 
 
 
 
 
 
 
 
 
Figure 4.4 L-655,238 (REV 5901 para-isomer) has no effect on medium osmolarity. 
 
Using VaproTM vapour pressure osmometer samples of control isotonic DMEM, DMSO (0.1 
%) and L-665, 238 (50 µM) supplemented DMEM were measured for osmolarity. The 
addition of nether DMSO or L-665,238 were observed to significantly alter medium 
osmolarity. N=20  
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Figure 4.5 L-655,238 (REV 5901 para-isomer) and its effect on cell volume.  
 
Bovine articular cartilage explants were pre-treated for 1 h with control isotonic DMEM, 
DMSO (0.1 %), REV 5901 (50 µM) or L-665,238 supplemented DMEM. Samples were 
loaded with Calcein AM (5 µM) and images were acquired with CLSM post treatment (A), 
using a x63 dipping objective imaging ‘top-down’ from the articular surface. To quantify cell 
volume ‘Iso surface’ volume analyses were used (B). Data are mean +/- SEM of N=9, n=40 
cells, *p<0.05, **p<0.01, ***p<0.001 all vs. control from three distinct experiments. Bar = 5 
µm 
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Figure 4.6 L-655,238 (REV 5901 para-isomer) and its effect on in situ bovine articular 
chondrocytes viability. 
 
Bovine articular cartilage explants were pre-treated for 1 h with control isotonic DMEM, 
DMSO (0.1 %), L-665,238 (A) (REV 5901-paraisomer; 50 µM) or REV 5901 (50 µM) (B) or 
supplemented DMEM. Samples were loaded with Calcein AM (5 µM) and PI (2 µM) subject 
to single impact (10 cm) and images were acquired with CLSM prior and post impact at 2, 5, 
10, 20 and 30 min. To quantify cell death Imaris spot analysis were used. Arrow denotes 
impact point. Data are mean +/- SEM of N=9, n=27 explants, *p<0.05, **p<0.01, ***p<0.001 
all vs. control from three distinct experiments.  
Condition 
Viability at 2 min 
(%) 
Viability at 30min 
(%) 
Control (280) 95.86 ± 0.27 89.08 ± 1.02 
DMSO 97.18 ± 0.27 90.08 ± 0.35 
L-665,238 97.45 ± 0.07   91.69 ± 0.59 * 
REV 5901 97.45 ± 0.39 94.56 ± 0.59 *** 
(A) (B) 
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4.2.3 Wortmannin and its effect on volume regulation. 
 
To try and dissect the exact mechanism of action of REV 5901, a series of 
pharmacological inhibitors was used to investigate the effect of these 
compounds on different cell signaling cascades. Wortmannin a fungal 
metabolite and specific inhibitor of phosphatidylinositol 3-kinase (PI3K), 
mitogen-activated protein kinase (MAPK) and myosin light-chain kinase 
(MLCK) has been extensively used to demonstrate the role of the PI3K in 
diverse signal transduction processes (Stain and Waterfield, 2000). 
Wortmannin causes apoptotic cell death (Qureshi et al., 2007) and inhibits 
cell volume recovery in different cells including PT3 (prostate cancer cell 
line), HTC (rat hepatoma cells) and U937 (human monocyte - macrophage 
cells) (Feranchak et al., 1998). Since inhibition of PI3K delays cell volume 
recovery (Otero et al., 2005, Lewis et al., 2011), wortmannin’s effects on 
REV 5901 inhibition of cell volume and protective effects on cell viability were 
determined.  
 
The osmolarity of wortmannin supplemented DMEM was investigated to rule 
out the possibility of it acting via osmotic mechanisms and it was observed 
that wortmannin did not significantly adjust the osmolarity medium 280.86 ± 
1.68 mOsm compared to control 280.71 ± 0.70 mOsm or the REV 5901 
supplemented medium (Figure 4.7).  
 
Cell shrinkage has previously been shown to be chondro-protective and 
therefore the effect of wortmannin was determined. In Chapter 3, cell 
shrinkage displayed a chondro-protective effect but when the cells were 
shrunk below 440.13 ± 16.42 µm3 cell viability post impact did not show 
significant changes compared to control samples (Figure 3.3). Cells 
incubated within wortmannin (10 nM) supplemented DMEM exhibited a 
significant decrease in cell volume from 716.14 ± 36.68 µm3 in control 
samples to 359.90 ± 12.23 µm3 (p<0.001); a decrease of 50 %. Cells pre-
treated with REV 5901 (50 µM) displayed a cell volume of 552.68 ± 24.38 
µm3 a reduction of 30 % compared to controls (p<0.01). However, when cells 
were treated with a combination of REV 5901 (50 µM) and wortmannin, there 
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was no synergistic effect observed compared to treatment of cell alone with 
each agent. In fact the combination treatment led to chondrocytes exhibiting 
the same volume as REV 5901 alone (Figure 4.8).  
 
Cell death was significantly increased following a single impact. Explants 
treated with wortmannin (10 nM) led to an increase in cell death as observed 
at 2 min post impact, where cell viability was reduced to 91.98 ± 0.41 % 
compared to 95.86 ± 0.27 % in control samples (p<0.001) The significant 
increase in cell death continued over the time-period such that at 30 min post 
impact, cell viability was reduced by an additional 8 % compared to control 
samples (p<0.001) and by 10 % compared to REV 5901 incubated samples 
(p<0.001). Interestingly, when a combination of REV 5901 (50 µM) and 
wortmannin was investigated, cell viability was restored to levels seen in 
control sample thus showing that protective effect of REV 5901 was inhibited 
by wortmannin. No significant difference in cell death measurements were 
recorded prior to impact trauma for explants incubated in wortmannin 
compared to control samples (Figure 4.9 A & B). 
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Figure 4.7 Wortmannin and its effect on medium osmolarity.  
 
Using VaproTM vapour pressure osmometer samples of control isotonic DMEM, DMSO (0.1 
%) and Wortmannin (10 nM) supplemented DMEM were measured for osmolarity. The 
addition of neither DMSO or wortmannin were observed to significantly alter medium 
osmolarity. N=20  
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Figure 4.8 The effect of Wortmannin and REV 5901 on in situ bovine cell volume.    
 
Bovine articular cartilage explants were pre-treated for 1 h with control isotonic DMEM, REV 
5901 (50 µM), wortmannin (WMN) (10 nM) or wortmannin (WMN) and REV 5901 
supplemented DMEM. Samples were loaded with Calcein AM (5µM) and images were 
acquired with CLSM post treatment (A) with a x63 dipping objective imaging the zone of 
cartilage ‘top-down’ from the articular surface. To quantify cell volume ‘Iso surface’ volume 
analyses were used (B). Data are mean +/- SEM of N=9, n=40 cells, *p<0.05, **p<0.01, 
***p<0.001 from three distinct experiments. Bar =5 µm 
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Figure 4.9 Pre-treatment with Wortmannin and REV 5901 on cell viability. 
 
Bovine articular cartilage explants were pre-treated for 1 h with control isotonic DMEM, REV 
5901 (50 µM), wortmannin (10 nM) or wortmannin (WMN) and REV 5901 supplemented 
DMEM. Samples were loaded with Calcein AM (5 µM) and PI (2 µM) and subject to single 
impact (10 cm) and images were acquired with CLSM prior and post impact at 2, 5, 10, 20 
and 30 min. To quantify cell death Imaris spot analysis were used. Data are mean +/- SEM 
of N=9, n=27 explants, *p<0.05, **p<0.01, ***p<0.001 all vs. control from three distinct 
experiments. Arrow denotes impact point. 
 
 
Condition 
Viability at 2 min 
(%) 
Viability at 30min 
(%) 
Control (280 mOsm) 95.86 ± 0.27  89.08 ± 1.02 
REV 5901 97.45 ± 0.39       94.56 ± 0.59 *** 
Wortmannin (WMN)    91.98 ± 0.41***     85.3 ± 0.50 *** 
WMN + REV 5901 95.85 ± 0.40 88.50 ± 0.25 
(B) (A) 
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4.2.4 Determining whether Calcium Signalling plays a role in the 
mechanism of action of REV 5901 in short term mechanical 
trauma. 
 
Calcium signaling forms part of a possible mechanotransduction pathway by 
which chondrocytes may alter their metabolism in response to mechanical 
loading (Lewis et al., 2007). The effect on cell shrinkage on chondro-
protection and the role of stretch activated calcium channel (SACC) was 
determined in Chapter 3.  Treatment with GdCl3, an inhibitor of SACC, 
exacerbated the effect of cell death even when the chondro-protective 
osmotic challenge was employed thus indicating that the SACC were 
involved in affording chondro-protection. Therefore, the chondroprotection 
offered by REV 5901 was tested in the presence of GdCl3 to determine 
whether its effects were via SACC. 
 
Bovine articular cartilage explants were pre-treated for 1 h with control 
isotonic, hypertonic (380 mOsm) DMEM or GdCl3 (100 µM) and hypertonic 
(380 mOsm) DMEM, or REV 5901 (50 µM), or REV 5901 (50 µM) with GdCl3 
(100 µM) supplemented DMEM and cell viability determined post impact at 2, 
5, 10, 20 and 30 min. Within the first two minutes post impact samples 
incubated with GdCl3 and stimulated with REV 5901 were observed to offer 
an enhanced protection against cell death that was significantly greater 
(95.36 ± 0.26 %) compared to samples with GdCl3  (89.33  ± 1.13 %, p<0.05) 
+ hyperosmotic DMEM (380 mOsm), data recorded for REV 5901 treated 
samples was 97.45 ± 0.39 %. However, with time progression post impact, at 
30 min cell death levels in samples pre-incubated with GdCl3 and stimulated 
with REV 5901 increased and shown to be significantly higher than control 
samples (p<0.01) and samples incubated with REV 5901 alone (p<0.001; 
Figure 4.10). These data suggests that the chondro-protective effect of 
REV5901 was abolished by GdCl3 thus pointing out the SACC as possible 
involvement. 
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Figure 4.10 REV 5901 and GdCl3 the effect on cell viability within cartilage explants.  
 
 Bovine articular cartilage explants were pre-treated for 1 h with control isotonic, hypertonic 
(380 mOsm) DMEM or GdCl3 (100 µM) and hypertonic (380 mOsm) DMEM, or REV 5901 
(50 µM), or REV 590 (50 µM) with GdCl3 (100 µM) supplemented DMEM. Samples were 
loaded with Calcein AM (5 µM) and PI (2 µM) and subject to single impact (10 cm) and 
images were acquired with CLSM prior and post impact at 2, 5, 10, 20 and 30 min. To 
quantify cell death Imaris spot analysis were used. Arrow denotes impact point. Data are 
mean +/- SEM of N=9, *p<0.05, **p<0.01, ***p<0.001 all vs. control from three distinct 
experiments.  
Experimental Condition 
Viability at 2 min 
(%) 
Viability at 30min 
(%) 
Control (280 mOsm) 95.86 ± 0.27 89.08 ± 1.02 
GdCl3 + Hyper (380mOsm) 89.33  ± 1.13 ***    79.55 ± 3.87 *** 
GdCl3+ REV 5901 95.36 ± 0.26  85.17 ± 1.64 ** 
Hyper (380 mOSm) 97.48 ± 0.30    95.50 ± 0.49 *** 
REV 5901 97.45 ± 0.39    94.56 ± 0.59 *** 
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Calcium mobilising mediators such as uridine 5’-triphosphate have been 
reported to cause a rise in intracellular calcium concentration ([Ca2+]i) in 
human articular chondrocytes (Koolpe et al., 2005). Therefore, it was 
investigated if uridine 5’-triphosphate would have a positive effect on cell 
viability and act in a similar manner to REV 5901 or exhibits no effect on cell 
mechanotransduction and viability, thus providing further evidence of the 
pathway involved. 
A significant decrease in the volume of in situ chondrocytes treated with 
uridine 5-’triphosphate (100 µM) was observed compared to control 
chondrocytes with a volume of 604.08 ± 24.33 µm3 compared to 716.14 ± 
36.68 µm3 (p<0.05) respectively, a 15 % decrease. However, chondrocyte 
cell volume following treatment with REV 5901 (50 µM) was still significantly 
lower than that observed with uridine 5’-triphosphate (100 µM; p<0.05).  
When analysing cell viability following incubation with uridine 5’-triphosphate 
(100 µM) it was observed that there were no significant changes in cell death 
levels compared to control within the first 20 min post impact (p>0.05), 
however at later time-points a decrease in PDC was observed for uridine 
treated samples with 91.78 ± 0.57 % compared to 89.08 ± 1.02 % (p>0.05) in 
control explants. This data shows that Ca2+ has once again been implicated 
to have an effect on chondrocyte cell volume (section 3.2.4 EGTA treated 
samples) but no effect over chondrocyte viability within 30 min post impact.  
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Figure 4.11 REV 5901 and Uridine: the effect on cell volume and viability within in situ 
articular chondrocytes.  
 
Bovine articular cartilage explants were pre-treated for 1 h with control isotonic DMEM, REV 
5901(50 µM), and Uridine (100 µM) supplemented DMEM. Panel A: Samples were loaded 
with Calcein AM (5 µM) and images were acquired with CLSM post treatment. To quantify 
cell volume ‘Iso surface’ volume analyses were used all pharmacological agents. Panel B: 
Samples were loaded with Calcein AM (5 µM) and PI (2 µM) and subject to single impact (10 
cm) and images were acquired with CLSM prior and post impact at 2, 5, 10, 20 and 30 min. 
To quantify cell death ‘Imaris spot analysis’ were used. Arrow denotes impact point. Data are 
mean +/- SEM of N=9, n=40 cells, n=27 explants, *p<0.05, **p<0.01, ***p<0.001 all vs. 
control from three distinct experiments. 
Experimental 
Condition 
Chondrocyte 
Volume Changes 
(µm3) 
Viability at 2 
min 
(%) 
Viability at 
30min 
(%) 
Control (280mOsm) 716.14 ± 36.68 95.86 ± 0.27 89.08 ± 1.02 
Uridine 578.46 ± 26.85 * 95.65 ± 0.37 91.78 ± 0.57 
REV 5901 552.68 ± 24.38 ** 97.45 ± 0.39  94.56 ± 0.59 *** 
(A) (B) 
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4.2.5 F-actin changes due to pharmacological interventions 
 
Previous studies have shown that the actin cytoskeleton plays a vital role in 
maintaining cell structure and the integrity of bovine articular chondrocytes 
(Gulilak et al., 1995, Guilak, 1999, Blain, 2009). Disruption of F-actin 
cytoskeleton with pharmacological agents have been reported to have 
negative effect on the relationship between matrix deformation and 
alterations in chondrocyte nucleus shape as well as a decrease chondrocyte 
stiffness (Gulilak et al., 1995, Tickery et al., 2004). Nevertheless, filamentous 
actin organisation has been noted to be less defined in OA suggesting a 
defective function of F-actin in OA (Blain, 2009). Therefore, it was important 
to investigate the effect of REV 5901 upon F-actin cytoskeleton. 
 
REV 5901 induced increase in the actin cytoskeleton within the SZ with 
78.72 ± 3.99 AU (p<0.01) compared to SZ cells from control samples (65.43 
± 3.99 AU). No significant differences were observed in the MZ, 61.17 ± 4.25 
AU for REV 5091 samples and 56.49 ± 8.98 AU (p>0.05) in control samples 
or in the DZ, 47.50 ± 2.12 AU and 53.13 ± 1.00 AU respectively (p>0.05). 
DMSO was noted not to alter F-actin organisation thus confirming that the 
chondro-protective effects of REV 5901 are independent from the vehicle 
used (Figure 4.12 B). 
 
F-actin organisation of in situ chondrocytes showed no significant changes in 
response to L-655,238 (REV 5901 para-isomer), regardless of cell zone 
location when compared to control samples (p>0.05; Figure 4.13). Data for 
SZ cells incubated in L-655,238 (50 µM) supplemented DMEM was 70.50 ± 
10.83 AU compared to 65.43 ± 3.99 AU in control samples. Similar trends 
were observed for the MZ cells (52.88 ± 7.63 AU vs 56.49 ± 8.98 AU control) 
or DZ cells (51.63 ± 36.39 AU vs 53.12 ± 1.00 AU control) thus indicating that 
L-655,238 (REV 5901 para-isomer) has no effect on cell cytoskeleton and 
perhaps explaining why it was less effective at preventing cell death over the 
time course investigated observed in section 4.2.1 (Figure 4.6). 
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Figure 4.12 Effect of REV 5901 on F-actin organisation. 
 
Cartilage explants were incubated in the presence of 50 µM REV 5901 and the polymerised 
actin cytoskeleton labelled with Alexa 488-phalloidin. Actin was analysed by linear profiles 
(A) for each zone and subsequently quantified (B). Data are mean +/- SEM of N=9, n=30 
cells *p<0.05, **p<0.01, ***p<0.001 all vs. control from three distinct experiments. 
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Figure 4.13 Effect of REV 5901 and L-665,238 on F-actin organisation.  
 
Cartilage explants were incubated 1 h in the presence of 50 µM REV 5901 or L-665,238 
(REV 5901 para-isomer) and the polymerised actin cytoskeleton labelled with Alexa 488-
phalloidin. Actin was analysed by linear profiles for each zone and subsequently quantified. 
Data are mean +/- SEM of N=9, n=30 cells *p<0.05, **p<0.01, ***p<0.001 all vs. control from 
three distinct experiments. 
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It was observed that wortmannin induced cell death (see section 4.2.3) 
following single impact trauma, therefore its effects on the F-actin 
cytoskeleton were determined. Samples were examined by linear profiling as 
previously described and the F-actin organization between different zones 
was analysed. This method was also used to determine whether there was a 
potential modulation of actin depolymerisation by REV 5901 within the 
chondro-protective mechanisms. 
Within the SZ, wortmannin significantly decreased F-actin by 30 % to 44.56 ± 
8.30 AU compared to control samples 65.43 ± 3.99 AU (p<0.05) and 40 % 
compared to REV 5901, 78.72 ± 3.99 AU (p<0.01). Interestingly, the same 
trend, where F-actin is significantly decreased within samples incubated with 
wortmannin was observed for samples of the MZ where a ~25 % decrease 
was recorded compared to both control samples 56.49 ± 8.98 AU and 61.17 
± 4.25 AU (p<0.05). There was no significant difference recorded for cells 
situated in the DZ for any of the experimental conditions (p>0.05; Figure 
4.14). 
Following identification that REV 5901 chondro-protective effects were 
inhibited by wortmannin treatment, as well as wortmannin was reducing cell-
viability post impact following treatment (Figure 4.10) the effect on F-actin 
organisation was determined. Interestingly, explants that had been in 
presence of REV 5901 exhibited increased levels of F-actin within all distinct 
zones but with no significant differences observed when compared to control 
samples alone with F-actin concentration of 68.41 ± 15.78 AU, 55.00 ± 10.75 
AU or 53.34 ± 8.43 AU in SZ, MZ and DZ respectively (p>0.05; Figure 4.14).  
Given the effects of Latrunculin B (an inhibitor of actin polymerisation) on 
actin polymerization (Figure 3.8), the effect of REV 5901 in the presence of 
Latrunculin B (Spector et al., 1989, Kerrigan and Hall, 2005) was determined 
on this parameter. Latrunculin B significantly reduced F-actin polymerisation 
for cells within all cartilage distinct zones with a 51 % reduction in SZ 
compared to control samples (p<0.001), 45 % for MZ  (p<0.01) and 45 % for  
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DZ (p<0.01). Since REV 5901 was able to inhibit F-actin depolymerisation of 
wortmannin (Figure 4.14), its was investigated whether it still afforded 
protection in the presence of Latrunculin B in cartilage explants thus offering 
its protection via an actin regulated mechanism. Samples incubated with 
REV 5901 and Latrunculin B were examined and it was observed that SZ 
cells showed a significantly different (15 %) change compared to control 
samples, whilst no significant effects in the MZ or DZ compared to control 
zones but were observed thus showing that REV 5901 was able to inhibit the 
inhibitory effect of Latrunculin B on actin polymerisation (p>0.05; Figure 
4.15). 
Finally the effect of REV 5901 on the F-actin organisation was observed in 
the presence of GdCl3. REV 5901 had reduced the inhibition on F-actin actin 
polymerisation from GdCl3. F-actin organisation of the chondrocytes within 
the cartilage explants was restored to control levels and no significant 
difference was observed within the three zones (p>0.05; Figure 4.16). 
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Figure 4.14 The effect of REV 5901 and wortmannin on F-actin organisation. 
 
Cartilage explants were incubated 1 h in the presence of 50 µM REV 5901, 10 nM 
wortmannin (WMN) or wortmannin (10 nM) with addition of REV 5901 (50 µM) and the 
polymerised actin cytoskeleton labelled with Alexa 488-phalloidin. Actin was analysed by 
linear profiles for each zone and subsequently quantified. Data are mean +/- SEM of N=9, 
n=30 cells *p<0.05, **p<0.01, ***p<0.001 all vs. control from three distinct experiments. 
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Figure 4.15 The effect of REV 5901 and Latrunculin B on F-actin organisation. 
 
Cartilage explants were incubated 1 h in the presence of 50 µM REV 5901, 10 µM 
Latrunculin B or Latrunculin B (10 µM) with addition of REV 5901 (50 µM) and the 
polymerised actin cytoskeleton labelled with Alexa 488-phalloidin. Actin was analysed by 
linear profiles for each zone and subsequently quantified. Data are mean +/- SEM of N=9, 
n=30 cells *p<0.05, **p<0.01, ***p<0.001 all vs. control from three distinct experiments. 
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Figure 4.16 The effect of REV 5901 and GdCl3 on F-actin organisation. 
 
Cartilage explants were incubated 1 h in the presence of 50 µM REV 5901, 100 µM GdCl3 or 
GdCl3  (100 µM) with addition of REV 5901 (50 µM) and the polymerised actin cytoskeleton 
labelled with Alexa 488-phalloidin. Actin was analysed by linear profiles for each zone and 
subsequently quantified. Data are mean +/- SEM of N=9, n=30 cells *p<0.05, **p<0.01, 
***p<0.001 all vs. control from three distinct experiments.  
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4.2.6 The effect of REV 5901 on actin binding proteins   
 
Mechanotransduction is very important for the cell integrity and cartilage 
tissue and has been implicated in response to mechanical loading (Wilkins et 
al., 2000). In chondrocytes, one of the integral functions of actin is to regulate 
the cell phenotype by adjustment of the cell shape and by providing the cell 
with mechanical integrity to resist compressive loads (Guilak, 1995, Durrant 
et al., 1999, Blain, 2009). Therefore it was important to investigate whether 
different manipulations over actin organisation would lead to subsequent 
changes in gene expression for the associated actin proteins. REV 5901 was 
shown to increase actin cytoskeleton to further characterise the functions of 
REV 5901, RNA was extracted from freshly isolated chondrocytes that were 
incubated with hyperosmotic (480 mOSM) DMEM, GdCl3 (100 µM) and 
stimulated with hyperosmotic (480 mOsm) DMEM and REV 5901 (50 µM) 
supplemented DMEM.  
  
Gelsolin is a Ca2+ regulated protein known to sever actin filaments and actin 
depolymerizing factor (ADF). Densitometric analysis showed that no 
significant changes in gelsolin were observed following treatment with 
hyperosmotic medium (0.82 ± 0.07-fold) compared to control (1.01 ± 0.27-
fold) expression (p>0.05). Gelsolin expression was significantly increased in 
chondrocytes treated with GdCl3 supplemented DMEM and hyperosmotic 
DMEM (p>0.001) from 3.68 ± 0.95-fold compared to 1.01 ± 0.27-fold in 
control samples an increase ~ 3 –fold. Conversely, REV 5901 decreased the 
levels of gelsolin from 1.01 ± 0.01-fold in control samples to 0.72 ± 0.10- fold 
(p<0.001) by approximately 30 % reduction. These data indicated that REV 
5901 treated cells exhibited a reduced expression of gelsolin, hence retaining 
a strong F-actin cytoskeleton by perhaps regulating gelsolin, with a Ca2+ flux 
(Figure 4.17). 
 
The actin depolymerising and severing protein cofilin, is re-activated by de-
phosphorylation induced by Ca2+ hence it was investigated in this study. 
Densitometric analysis (Figure 4.18) of the band intensity showed significant 
changes in the expression of cofilin were observed when chondrocytes were 
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treated with REV 5901. The levels of cofilin were reduced from 1.00 ± 0.06- 
fold to 0.72 ± 0.03- fold (p<0.001), by decrease of 30 %. Interestingly, when 
chondrocytes were incubated with GdCl3 (100 µM), followed by incubation 
with hyperosmotic DMEM no significant difference was observed in cofilin 
expression with 1.15 ± 0.07-fold and 0.98 ± 0.16-fold, respectively.  
 
Profilin has been shown to antagonise the effects of cofilin over actin (Sun et 
al., 1995). mRNA analysed from chondrocytes treated with hyperosmotic 
DMEM profilin expression was detected and observed to be significantly 
higher than chondrocytes in control samples with 2.12 ± 0.14- fold compared 
to 1.01 ± 0.09- fold (p<0.001) in control samples. Gd3+ inhibition of the SACC 
was observed to reduce the levels of profilin significantly to 0.68 ± 0.03- fold 
(p<0.001) a reduction of ~30 %. Whereas REV 5901 increased the level of 
profilin over control chondrocytes with 4.46 ± 0.22- fold over the control 
samples (p<0.001) and its effect was greater than the effect induced by 
hyperosmotic medium alone (Figure 4.19). 
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Base pair size 
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 300 bp 
  
 
 
Experimental 
Condition Control HYPER HYPER+Gd3+ REV 5901 
Data from 
Densitometry 1.00 0.82 3.68 0.72 
 
 
Figure 4.17 Effect of different treatments on Gelsolin mRNA expression in 
chondrocytes. 
 
Gelsolin mRNA was determined by reverse transcriptase polymerase chain reaction (RT-
PCR) analysis on freshly isolated bovine articular chondrocytes treated for 1 h with 
hyperosmotic (480 mOsm) DMEM, REV 5901 (50 µM) and combination of GdCl3  (100 µM) 
and hyperosmotic (480 mOsm) DMEM. A representative gel image is shown (A), along with 
the numeric data obtained by densitometry analysis of the gel (B). Data are mean +/- SEM of 
N=3 samples, *p<0.05, **p<0.01, ***p<0.001 all vs. control. 
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Figure 4.18 Effect of different treatments on Cofilin mRNA expression in 
chondrocytes. 
 
Cofilin mRNA was determined by reverse transcriptase polymerase chain reaction (RT-PCR) 
analysis on freshly isolated bovine articular chondrocytes treated for 1 h with hyperosmotic 
(480 mOsm) DMEM, REV 5901 (50 µM) and combination of GdCl3  (100 µM) and 
hyperosmotic (480 mOsm) DMEM. A representative gel image is shown (A), along with the 
numeric data obtained by densitometry analysis of the gel (B). Data are mean +/- SEM of 
N=3 samples, *p<0.05, **p<0.01, ***p<0.001 all vs. control. 
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Figure 4.19 Effect of different treatments on Profilin mRNA expression in 
chondrocytes. 
 
Profilin mRNA was determined by reverse transcriptase polymerase chain reaction (RT-
PCR) analysis on freshly isolated bovine articular chondrocytes treated for 1 h with 
hyperosmotic (480 mOsm) DMEM, REV 5901 (50 µM) and combination of GdCl3  (100 µM) 
and hyperosmotic (480 mOsm) DMEM. A representative gel image is shown (A), along with 
the numeric data obtained by densitometry analysis of the gel (B). Data are mean +/- SEM of 
N=3 samples, *p<0.05, **p<0.01, ***p<0.001 all vs. control. 
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4.2.7 The role of actin binding proteins in the mechanism of action 
of REV 5901 
 
F-actin repetitively has been shown to be involved in cartilage chondrocyte 
mechanotransduction (Guilak, 1995, Grodzinsky et al., 2000, Han et al., 
2012) influenced by mechanical loading, osmotic environment and 
inflammation, all of which are associated with OA (Borelli et al., 1997, 
Goldring and Goldring, 2007, Guilak, 2011). Manipulation of osmotic 
pressure results in remodelling of the actin cytoskeleton with exposure to 
hypo-osmotic stress leading to F-actin depolymerisation and reorganization 
(Chao et al., 2006, Blain, 2009). On the other hand, F-actin depolymerizing 
agents lead to reduced cell viability within in situ chondrocytes (Figure 3.6) 
therefore, it was important to investigate the role of actin binding proteins and 
their involvement in conveying the chondro-protective effects of REV 5901. 
 
To access the influence of REV 5901 on the intracellular pathways of 
chondrocytes, eleven different conditions were compared: bovine cells before 
treatment (control 380 mOsm), cells treated with hyperosmotic (480 mOsm) 
DMEM, cells treated with REV 5901 and its para-isomer L-665,238, 
wortmannin, Latrunculin B, Uridine and combinations with REV 5901 
including with GdCl3. Protein was extracted from chondrocytes following 
treatment and subjected to SDS-PAGE. Membranes were then probed for 
cofilin, profilin and gelsolin, previously shown as F-actin modulators and 
related to OA (Chao et al., 2006, Blain, 2009). Interestingly, only gelsolin and 
cofilin were detected with western blotting. Gelsolin is known to sever actin 
filaments thus acting as ADF and it is also known that these alterations are 
activated by Ca2+ that on the other side synergistically promote gelsolin 
binding to actin filaments. Densitometric analysis of the band intensity 
(Figure 4.20 & 4.21) revealed that REV 5901 had no significant effect over 
basal levels. Samples treated with REV 5901 showed exactly the same 
behavior as hyperosmotic (480 mOsm) DMEM and L-665,238 treated 
samples with 1.01 ± 0.04-fold and 0.91 ± 0.02-fold respectively therefore 
showing no significant difference from REV 5901 or control samples (p>0.05; 
Figure 4.20). 
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When wortmannin the PI3K inhibitor was used, expected increases in 
gelsolin was observed with a 1.18 ± 0.04-fold increase compared to control 
(p<0.05; Figure 4.21). A combination of wortmannin stimulation by REV 5901 
led to a reduction in gelsolin levels compared to wortmannin alone. This 
reduction was not significantly different from control and REV 5901 treated 
samples alone, thus suggesting that REV 5901 exhibits its chondro-
protective effects via a PI3K dependent mechanism.  
 
Samples treated with either uridine did not show any significant differences in 
gelsolin levels from control samples. It was observed that samples treated 
with Latrunculin B significantly increased gelsolin levels with 1.11 ± 0.04-fold 
increase thus showing that depolymerisation of actin cytoskeleton was partly 
being inhibited by gelsolin (p<0.05) compared to control samples (Figure 
4.21).  
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Figure 4.20 Effect of different treatments on Gelsolin protein expression in 
chondrocytes. 
 
Freshly isolated bovine cells were incubated 1 h in the presence of control (isotonic 380 
mOsm), hyperosmotic (480 mOsm) DMEM, DMSO (0.1 %), REV 5901 (50 µM) and L-
655,238 (50 µM). Western blot analysis were utilised by standard procedures and a 
representative blot is shown (A), along with the numeric data obtained by densitometry 
analysis of the blots (B). Densitometry analysis were carried out with ImageJ® software. 
N=3,  *p<0.05, **p<0.01, ***p<0.001 all vs. control. 
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Figure 4.21 Effect of different treatments on Gelsolin protein expression in 
chondrocytes. 
 
Freshly isolated bovine cells were incubated 1 h in the presence of control (isotonic 380 
mOsm), hyperosmotic (480 mOsm) DMEM, DMSO (0.1 %), REV 5901 (50 µM) and both 
alone and in combination with pharmacological agents. Western blot analysis were utilised 
by standard procedures and a representative blot is shown (A), along with the numeric data 
obtained by densitometry analysis of the blots (B). Densitometry analysis were carried out 
with ImageJ® software. N=3,  *p<0.05, **p<0.01, ***p<0.001 all vs. control. 
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Cofilin is a known actin depolymerizing protein (ADP) and together with the 
cofilin/ADF family they disassemble F-actin from the actin network and 
recycle the actin monomers (Bokoch et al., 2006, Blain, 2009). Signalling 
through specific pathways can trigger the formation of distinct actin-
dependant structures therefore, it was important to know how REV 5901 
regulates the behaviour and the organisation of actin cytoskeleton.  
 
Densitometric analysis of the band intensity (Figure 4.22) revealed that REV 
5901 significantly reduced cofilin by 28 % to 0.79 ± 0.07-fold (p<0.05) 
compared to control. Wortmannin significantly increased cofilin levels with 
4.49 ± 0.08-fold (p<0.05) increase compared to control, whereas treatment in 
combination with REV 5901 reduced expression of cofilin significantly by 65 
% to 1.53 ± 0.06-fold (p<0.01) over control (p<0.05). L-665,238 did not 
significantly alter cofilin expression compared to control. Latrunculin B a 
known actin depolymerizing agent-increased cofilin levels by 60% to 2.48 ± 
0.04-fold compared to control sample (p<0.01) and by 70 % compared to 
REV 5901 alone (p<0.01).  
 
Interestingly, the addition of hyperosmotic (480 mOsm) DMEM did not 
reduce cofilin expression thus showing that the pathway behind the 
hyperosmotic alteration might be different from the one, which REV 5901 
acts. When samples were incubated with GdCl3, cofilin was significantly 
increased compared to control and REV 5901 samples with 1.30 ± 0.05-fold 
and 1.26 ± 0.04-fold (p<0.05), however both are lower than that observed 
with Latrunculin B and wortmannin (p<0.01). 
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Figure 4.22 Effect of different treatments on Cofilin protein expression in 
chondrocytes. 
 
Freshly isolated bovine cells were incubated 1hr in the presence of control (Isotonic 380 
mOsm) DMEM, hyperosmotic (480 mOsm) DMEM, DMSO (0.1%), REV 5901 (50 µM), L-
655,238 (50 µM), Wortmannin (10 nM), Latrunculin B (10 µM), combination of GdCl3  (100 
µM) and hyperosmotic (480 mOsm) DMEM, GdCl3  (100 µM) and REV5901 (50 µM) DMEM 
and Wortmannin and REV 5901 (50 µM) DMEM. A representative blot is shown (A), along 
with the numeric data obtained by densitometry analysis of the blots (B). Densitometry 
analysis were carried out with ImageJ® software. Data are mean +/- SEM of N=3 samples,  
*p<0.05, **p<0.01, ***p<0.001 all vs. control.  
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4.3 Summary  
 
Investigation of the possible chondro-protective properties of panel of 
pharmacological compounds revealed that REV 5901 was the most efficient 
at reducing cell death. 
 
All the investigated agents were observed to decrease cell volume prior to 
mechanical impact by osmotically independent mechanisms supporting the 
observations that cell shrinkage is a chondro-protective mechanism, however 
once chondrocytes volume decreased to a certain level the chondro-
protective effect was no longer enhanced supporting the observations in 
Chapter 3. Inhibition of the PI3K pathway by wortmannin increased cell death 
even though wortmannin reduced cell volume. When REV 5901 was used in 
combination with wortmannin the levels of cell death were not significantly 
different from control thus suggesting that the effect of REV 5901 was 
abolished by wortmannin suggesting that the protective effects of REV 5901 
are in part via a PI3K dependent mechanism. 
 
The fact that REV 5901 protected chondrocytes from impact load was 
surprising and appears to mimic the effects induced by hypertonic induced 
shrinkage. Indeed, data suggests that REV 5901 is able to induce cell 
shrinkage, whilst a rise in [Ca2+]i is not enough to stimulate a decrease in cell 
volume, suggesting that the REV 5901 induced rise in [Ca2+]i may not be 
directly involved in the associated volume change and most likely involved 
with the regulation of the polymerised actin cytoskeleton.  
 
When F–actin was analysed it was observed to be increased in the 
superficial zone (SZ) by REV 5901 but not in the other two distinctive zones, 
thus showing that perhaps the difference in behaviour of the chondrocytes 
from different zones should be investigated. It is well documented that the 
actin-regulatory proteins are calcium-dependent (Erickson et al., 2003, Chao 
et al., 2006, Blain, 2009) and in chondrocytes shown that changes in [Ca2+]i 
are involved in cytoskeletal re-organisation following osmotic challenge 
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(Figure 3.7) and REV 5901 incubation (Figure 4.12; Langelier et al., 2000, 
Chao et al., 2006). 
 
To summarise, REV 5901 decreased chondrocyte volume and reduced cell 
death, increased F-actin in the superficial zone. It was also shown to have 
significant effect over the actin regulation proteins on molecular level and to 
be involved in the PI3K pathway. REV 5901 displayed chondro-protection 
and thus could be a used to develop selective compounds for novel 
prospective agent that can targeting short-term impact trauma hence it is 
important to investigate its action and regulation. 
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Osteoarthritis (OA) is the most common form of arthritis (ARC, 2008, Loeser, 
2011, Teeple at al., 2013), which causes pain and disability to 8 million 
people within the UK (ARC, 2008) and 27 million individuals in USA 
(Lawrence et al., 2008) it is also known to be the biggest contributor to 
claimants for disability living allowance in UK (ARC, 2008). Additionally, OA 
is the single largest indication for primary hip, knee and ankle replacement 
procedures in the UK recorded in 2010 with 93 %, 97 % and 72 % of the 
cases accordingly (National Joint Registry, 2011). Nevertheless, the burden 
of OA is not only in its prevalence but its economic impact is also of 
significant concern. Solely in the UK, it is estimated that OA brings an 
economic cost to the nation of approximately £5.7 billion, annually (ARC, 
2008). Considering the prevalence and the significant economic, social and 
psychological costs of OA, it is not surprising that ongoing research into 
prevention of OA is an ever growing field. OA is a chronic disease with a 
multifactorial etiology with age being the most prominent feature (Felson and 
Zhang, 1998, Goldring and Goldring, 2007, Loeser, 2011). In addition, 
mechanically induced pathophysiological changes to the articular cartilage, 
subchondral bone and joint tissues can cause OA, with obesity (Felson, 
1996, Iannone and Lapadula, 2010), labor and neuromuscular dysfunction 
(Buckwalter and Mankin, 1998, Buckwalter and Martin, 2004, Lotz and 
Kraus, 2010) and, high-impact sports (Felson and Andesron, 1988, Kujala et 
al., 1995, Saxon et al., 1999, Roos, 2005, Urquhart et al., 2007) being 
implicated.  
 
Research is gradually clarifying the response of cartilage to mechanical load 
and oxidative stress, be it following trauma or related to joint overloading, 
thereby allowing us to intercept the pathophysiological process earlier and 
decrease the burden of OA on society. This study has investigated the short-
term cellular responses of chondrocytes to static mechanical impact and the 
effects of possible chondro-protective agents/pathways involved. This has 
allowed for a better understanding of the effects of loading on cartilage 
tissue, identifying valuable strategies and preventive mechanisms for 
individuals involved with short-term high impact or repetitive loading exercise. 
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The magnitude of stress measured in vivo in baseline physiological stress 
during normal walking has been calculated to be between 2 and up to 5 MPa 
(Urban, 1994) increasing to 18-20 MPa when rising from a chair (Hodge et 
al., 1986). Exercise such as running or jumping contributes to physiological 
stresses significantly higher than the measurements recorded during walking 
and thus potentially can cause tissue injury. Previous studies have reported a 
number of models used to induce various impact forces (static or dynamic) 
and test parameters (weight, height and force) by utilisation of a ‘drop tower’ 
and pendulum devices. Impact heights reported in the literature range from 
2.5 cm (Huser and Davis, 2007, Jeffrey and Aspden, 2007) to 50 cm (Jeffrey 
et al., 2005) and the variation of weights used between 0.1 kg (Aspden et al., 
2002, Bush et al., 2005) to 1 kg (Repo & Finlay, 1977, Jeffrey et al., 1995, 
Vetramo and Sheedhom, 2007). These translate to impact forces between 1-
25 N therefore, utilization of models with impact forces and delivering stress 
between 1-40 MPa can cause cell death and rupture(s) upon administration 
to articular chondrocytes and cartilage tissue (Repo and Finley, 1977, Chen 
et al., 2001, Jeffrey et al., 2005, Han et al., 2012).  
 
In this study a drop tower impact model was used (Jeffrey et al., 1995, Bush 
et al., 2005, Huser and Davis, 2007), delivering force of 1.34 N, where the 
chondrocyte response was investigated. The drop tower technique although 
a useful method of stimulating impact (Aspden et al., 2002) was not used to 
replicate in vivo pressures, nor to study matrix damaging injurious loads, but 
to provide a sufficient force to investigate biological responses of articular 
cartilage and thus highlight potential areas of interest for chondro-protection. 
It is important to underline that within this model, the tissue does not have the 
protection offered by the sub-chondral bone and synovial fluid that are 
afforded to them in vivo (Bush et al., 2005, Jeffrey et al., 2005). There is a 
consiferable interest in the role of the sub-chondral bone and studies suggest 
(Chen et al., 2003, Amin et al., 2009) that the sub-chondral bone may also 
interact with articular cartilage via soluable mediators and influence 
chondrocyte survival of in vitro cartilage sapmles during culture. Amin et al., 
2009, showed that the removal of the sub-hondral bone within in vitro 
samples, results in significant increase of persantege cell death soleily within 
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the superfisial zone over seven days thus underlying that chondrocyte 
survival will be influenced during culture. To minimise any effects related to 
the absence of the sub-chondral bone all cartilage explants used in this study 
were incubated for less than 4 days. 
 
In this study an automated cell-counting technique was used (Nedelcheva et 
al., 2008). Using a validated and reproducible computer generated cell-
counting technique to quantify cell death (Jomha et al., 2003, Amin et al., 
2010). There is always a potential for error in such automated systems such 
as uneven dye loading or dye leakage, photo bleaching, unequal cell 
thickness, background caused by free protein or autoflorescence, etc. 
However, with computer based automated methods the error will be 
consistent between different images, therefore unlikely to effect subsequent 
conclusions. Lastly, the external osmolarity of in situ chondrocytes has not 
been measured directly. Cartilage tissue contains high concentration of free 
cations (Na+) and low concentration of anions (Cl-) compared to its 
surroundings and the precise values verified by the Gibbs-Donnan 
equilibrium conditions (Urban et al., 1993, Urban, 1994). Thus a rise in 
medium osmolarity involves a corresponding rise of osmolarity in cartilage 
ECM that is evident from the reciprocal change observed (Figure 5.1) where 
by a mathematical calculation for estimating extracellular osmolarity of in situ 
volume changes have been described (Bush and Hall, 2001b). 
5.1 Chondrocyte viability and mechanical injury  
 
Blunt trauma and single injurious impact have been previously shown to 
compromise the mechanical properties of cartilage and reduce chondrocyte 
viability (Torzilli et al., 1999, Bush et al., 2005, Jeffrey et al., 2005, Lee et al., 
2005, Vetramo and Sheedhom, 2007, Han et al., 2012). Here the data 
showed that mechanical impact induced cell death of in situ articular 
chondrocytes during the first 2 minutes post mechanical injury, followed by 
an increasing death at the end of the observation period (30 minutes) (Figure 
3.1 & 3.2). These data are in agreement with previous studies showing that 
chondrocyte death occurs following injurious mechanical load (Tew et al., 
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2000, Bush and Hall, 2001b, Chen et al., 2001, D’Lima et al., 2001b, Bush et 
al., 2005, Amin et al., 2008) with cell death reported from as early as 3 min, 
and more extensive death by 25 min within the SZ (Bush et al., 2005). In 
addition to using a drop tower (Aspden et al., 2002, Bush et al., 2005, Jeffrey 
et al., 2005, Jeffrey and Aspden, 2007) to deliver the stress, scalpel injury 
(Amin et al., 2008, Amin et al., 2010), cyclic compression as well as a variety 
of loading rates (Ewers, 2001, Huser and Davis, 2007, Han et al., 2012) have 
been used. So whilst mechanical load has been used to identify cell death, 
mechanism(s) (i.e., whether a necrotic, apoptotic or other process) are not 
affirmative and poorly understood.  
 
The role of [Ca2+]i in chondrocyte mechanotransduction has been studied 
intensively over the past few years and it would appear that the role of this 
prevalent intracellular secondary messenger is diverse and may depend 
upon numerous factors including: chondrocyte species, morphology, culture 
conditions and phenotype (Dascalu et al., 1996, Pritchard et al., 2002, 
Kerrigan and Hall, 2008). Previous work in bovine in situ chondrocytes 
reported that ethylene glycol tetraacetic acid (EGTA) prevented superficial 
chondrocyte death post-scalpel induced injury compared to calcium 
containing conditions (Amin et al., 2009, Amin et al., 2010). Therefore, to 
further study the mechanism of chondrocyte death post mechanical trauma 
[Ca2+]o was removed with the addition of 2 mM EGTA, which chelates 
calcium ions.  EGTA incubation was observed to have no significant impact 
over cell death in the initial stages (2 – 5 min) or at 30 min phase post 
mechanical trauma (Figure 3.4) conversely it was observed that chondrocyte 
cell volume was reduced thus exhibiting one of the universal trait of 
apoptosis (Bortner, 2005) indicating that perhaps initial stages of cell death 
post impact may be independent of calcium changes.   
 
The data presented here suggest a role for both necrosis and apoptosis with 
chondrocyte death post injurious impact by necrosis likely to be the result of 
the blunt trauma at the point of impact and apoptosis to be spreading in the 
later stages ~ 30 min post loading (Tew et al., 2000, D’Lima et al., 2001a, 
Borelli, 2006, Pelling et al., 2009). Similar observations have been previously 
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shown (Bush et al., 2005), however the mechanism involved in the short-
term death post mechanical impact needs to be further investigated, as only 
a few studies have looked at the initial cell death phases followed by 
observation at 2 hours post-impact. This study thus investigated a poorly 
understood area and suggests that initial chondrocyte death is necrotic. 
5.2 Chondrocyte volume and viability in response to 
mechanical injury 
 
Articular chondrocytes are constantly exposed to changing extracellular 
environment (Stockwell, 1971) and they need to be able to dynamically 
respond to variety of pressures due to mechanical loading depending on 
activity and loading by altering their extracellular environment (Urban, 1994). 
However chondrocytes, similar to many other cell types, are known to be 
osmotically sensitive whereby alterations in the extracellular osmolarity 
prompt a volume-regulation response (Bush and Hall 2001b, Amin et al., 
2010, Han et al., 2012). It has been previously observed (Bush and Hall, 
2001b) that chondrocytes behave as perfect osmometers by following the 
Boyle-Van’t Hoff relationship and this observation was further confirmed by 
the data presented in this study (Figure 5.1). Both in situ and isolated (Po) 
chondrocyte volume changes were proportional to osmotic changes thus 
further validating the Imaris Iso-surface volume analysis used. Furthermore, 
changes in relation to cell volume and ECM metabolism have been 
associated with the degenerative changes of cartilage that characterise OA 
(Buckwalter, 1977, Goldring and Macu, 2009). 
 
Explants were exposed to a range of hyperosmotic (380 mOsm, 420 mOsm, 
540 mOsm) challenges for 1 h at 37o C prior to mechanical loading to induce 
cell shrinkage and determine an optimal chondro-protective osmolarity. In 
situ chondrocytes were observed to decrease their volume following an 
increase in osmolarity resulting in an increased chondrocyte viability that 
reached its limitation when 540 mOsm hypertonic challenge was applied 
(Figure 3.3). The data reported in this study supports previous studies 
demonstrating that in situ chondrocyte shrinkage by rising medium osmolarity 
can protect the cell from mechanical loading and thus can act as a chondro-
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protective mechanism following mechanical load (Bush et al., 2005, Amin et 
al., 2008, Amin et al., 2010). 
 
 
 
 
 
Figure 5.1 Boyle-Van’t Hoff relationship in osmotically induced chondrocytes. 
 
Chondrocyte mean volume plotted against reciprocal of the extracellular osmolarity following 
Boyle-Van’t Hoff relationship. The y-intersept was the osmotically inactive volume b, 130 
µm3. The line of best fit has a regression coefficient (r2=0.988) indication that in situ 
chondrocytes behave as perfect osmometers.  
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Converse to the data from this study, it has been reported that, exposure of 
cartilage to a high osmolarity of 600 mOsm, decreased the extent of cell 
death in the superficial zone (Amin et al., 2010) post mechanical injury. 
However, the authors of the afore-mentioned study used a different model, 
causing mechanical injury by scalpel blade thus potentially explaining the 
differences observed. Interestingly, Negoro et al., 2008 reported that that 
over six days chondrocytes exposed to 570 mOsm have been shown to 
develop apoptosis and oncosis features (e.g. reduced cell size, apoptotic 
bodies fragmentation of the nucleus and blebbing) thus suggesting that 
increased level of osmolarity can have a negative effect on long-term cell 
viability. Urban et al., 1993, reported that changes to cartilage hydration that 
prompt alterations in cell volume can influence the matrix metabolism. 
However, volume regulation will occur but the matrix metabolism will be 
determined hours later. 
 
In many cell types an alteration in cell volume is responsible for triggering 
recovery mechanisms that include the activation of intracellular signaling 
cascades (Lang et al., 2004, Lang, 2007). Over a decade ago, Erickson et 
al., 2001, indicated that hyper osmotic stress can cause significant volume 
change in chondrocytes, potentially activating an intracellular second 
messenger signal by inducing transient increases in intracellular calcium ion 
[Ca2+]i. These observations were consistent in a number of studies (Pritchard 
et al., 2002, Erickson et al., 2003, Kerrigan et al., 2008, Pritchard et al., 
2008) in this work we also showed that  [Ca2+]i is involved in changes in cell 
volume when hyperosmotic shock is applied (Chapter 3.2.2) and therefore, 
an inhibitor was used to study chondrocyte mechanotransduction via stretch 
activated ion channel (SACC). Gadolinium chloride (Gd3+), is a trivalent 
lanthanide known to block stretch-activated calcium channels, and previously 
shown to inhibit [Ca2+]i rise in response to hyper and hypo-tonic challenge 
(Erickson et al., 2001, Kerrigan and Hall, 2008, Parker at al., 2010), fluid flow 
(Yellowley et al., 2000) and direct mechanical stimulation (Guliak et al., 
1999a). Gadolinium chloride exacerbated cell death within the presence of 
hyper osmotic challenge thus further implicating [Ca2+]i as an important 
mediator for cell volume regulation.  
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Since volume and cell cytoskeleton have been linked in a number of studies 
(Guilak et al., 1995, Durrant et al., 1999, Kerrigan and Hall, 2005, Chao et 
al., 2006, Sasazaki et al., 2008). Research carried out by Parkkinen et al., 
1995, Durrant et al., 1999, Erickson et al., 2003, Pelling et al., 2009, have 
examined remodelling of the cytoskeleton in response to mechanical stimuli 
thus the effect of cell death in response to known F-actin modulators was 
investigated. Latrunculin B acts as F-actin disrupting agent and 
Jasplankinolide acts to stabilise actin in its filamentous form. It was observed 
that PDC was increased by 5 % when Latrunculin B disrupted the F-actin 
cytoskeleton whereby Jasplankinolide PDC was decresed with 5 %, thus 
suggesting that F-actin plays an important role in cellular responses minutes 
post mechanical loading. The results presented here are consistent with 
previous studies where following F-actin polymerisation (Chao et al., 2006, 
Sasazaki et al., 2006). 
 
REV 5901 inhibits chondrocyte RVD (Bush and Hall, 2001, Kerrigan and 
Hall, 2005, Kerrigan and Hall, 2008) and causes an increase in [Ca2+]i 
(Qusous et al., 2012). Recently it was shown that REV 5901 could induce 
volume changes under isotonic conditions (Qusous et al., 2012). REV 5901 
protected chondrocytes from impact load and appears to mimic the effects 
induced by hypertonic induced cell shrinkage. This would suggest that REV 
5901 induced rise in [Ca2+]i  where by this rise can be directly involved in the 
associated volume change or it can be involved with the regulation of the 
polymerised actin cytoskeleton or both. It is well documented that the actin-
regulatory proteins are calcium-dependent (Young et al., 1994) and in 
chondrocytes it has been shown that changes in [Ca2+]i are involved in 
cytoskeletal re-organisation following osmotic challenge (Erickson et al., 
2003, Pritchard et al., 2008). Articular cartilage explants were incubated with 
wortmannin (a specific PI3K inhibitor), uridine (a mediator of intracellular 
calcium rise) and gadolinium chloride (Gd3+), a trivalent lanthanide known to 
block stretch-activated calcium channels alone or in the presence of REV 
5901. The PI3K pathway has been shown to play a role in cell growth, 
proliferation and cell survival and is also known to activate IP3 sensitive 
intracellular calcium store release. Following inhibition of PI3K by wortmannin 
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and eliminating the effect of REV 5901 we implicated that store mediated 
[Ca2+]i post impact plays role in the way REV 5901 acts. Since calcium is 
important regulator of the mechanisms of cell death and cytoskeletal 
reorganisation the calcium mobilising mediator uridine 5’-triphosphate was 
also used to further understand the mechanisms of action REV5901 exhibits. 
Previously it was noted that alteration in cell volume is responsible for 
triggering recovery mechanisms that include the activation of intracellular 
signaling cascades. Thus it was not unexpected that articular chondrocytes 
reduced their volume post impact in the presence of uridine, what was 
interesting was that reduced cell volume did not significantly change PDC 
from control samples pointing that volume regulation, changes in calcium and 
the addition of a third modulator such as the cell cytoskeleton must be 
involved in chondro-protective mechanisms. 
5.3 Role and organisation of F-actin cytoskeleton within in 
situ chondrocytes 
 
 
The lack of RVI and the hypertonic stimulation of actin polymerisation 
together suggest a simple yet potent pathway by which cartilage protects 
against joint loading and impact and specifically how this relates to the zonal 
structure of the tissue. Indeed, a recent study has shown that in response to 
compression, the SZ experiences greater changes in cell volume, height and 
chondron structure when compared to the other two zones suggesting that 
the SZ may responded differently with regards to the regulation of the actin 
cytoskeleton (Pritchard et al, 2008). As loading results in progressive fluid 
expression from cartilage and an increase in extracellular osmolarity 
(Maroudas and Bannon, 1981), this will cause decrease in chondrocyte cell-
volume, a rise in [Ca2+]i and depolymerisation of the actin cytoskeleton 
without RVI. This would confer an increase in both the stiffness and Young’s 
modulus of the cells (Guilak et al., 2002) thus causing a greater protection 
against loading and trauma. This assumption would therefore suggest that 
fissures which disrupt the collagen network that otherwise prevent the 
maximal hydration of the cartilage proteogylcan, will result in localised areas 
of lower cartilage osmolarity, changes in cellular homeostasis including 
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resting cell volume (Bush et al., 2005) and actin depolymerisation (Pritchard 
et al, 2008). Furthermore, the progression of OA, and the loss of zones 
(Buckwalter, 2002) will subsequent exacerbate cartilage damage as 
chondrocytes in the MZ and DZ are less equipped to withstand impact force.  
 
A key inhibitor used to study chondrocyte mechanotransduction is gadolinium 
chloride (GdCl3), known to block stretch-activated calcium channels (Wright 
et al., 1996) previously shown to inhibit [Ca2+]i rise in response to hyper and 
hypo-tonic challenge (Sanchez and Wilkins, 2004, Kerigan and Hall, 2008) 
fluid flow (Yellowley, 2000) and direct mechanical stimulation. It is therefore 
conceivable that the changes in [Ca2+]i observed here may relate to the 
regulation of the polymerised actin cytoskeleton and not directly to volume 
regulation. In the SZ zone there was a 30 % increase in actin polymerisation 
inhibited by 43% following treatment with gadolinium chloride (GdCl3) and 
completely abrogated following the removal of extracellular calcium and the 
addition of EGTA. In the MZ the hypertonic challenge didn’t cause increase 
in actin polymerisation, but F-actin was istill inhibited by 35 % using 
gadolinium chloride (Gd3+). In the DZ, there was no change in actin 
concentration. These data strongly suggested a zonal specific regulation of 
the actin cytoskeleton with differing dependencies on intracellular calcium, 
whereby in the SZ, actin was regulated by stretch sensitive channels and 
was solely dependent upon an influx from the extracellular environment. 
Indeed, studies of the zone of articular cartilage have shown differences in 
chondrocyte gene expression (Youn et al., 2006), as well as actin 
organisation and viscoelastic properties (Darling et al., 2006). 
 
In a similar fashion to gadolinium chloride (Gd3+), wortmannin (specific 
inhibitor of PI3K), and Latrunculin B (an inhibitor of actin polymerisation) 
significantly reduced actin polymerisation within cartilage zones. Wortmannin 
inhibited actin polymerisation by 30 % compared to control samples and its 
depolymerising effect was also detected in the MZ (20 %) with no significant 
changes recorded for the DZ. Latrunculin B significantly reduced F-actin 
polymerisation by 51 % with the SZ compared to control samples and by 45 
% in both MZ and DZ cells compared to control. Interestingly, REV 5901 was 
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not observed to block the effect of gadolinium chloride, wortmannin. 
Conversely, it was observed to block Latrunculin B in regards to the F-actin 
cytoskeleton polymerisation thus suggesting that REV 5901 can regulate 
actin polymerisation by a number of mechanisms. To investigate the 
mechanism involved and to understand the effects on actin polymerization 
the changes in expression of F-actin calcium regulated proteins were 
observed. 
 
5.4 Changes in expression of F-actin, calcium regulated 
proteins in the mechanism of action of REV 5901 
 
 
The expression of F-actin regulated proteins have not been investigated in 
depth and are yet to be elucidated. In this study we observed their function in 
relation to REV 5901 and its mechanism of action. It is important to note that 
the data recorded is at a preliminary stage and a more extensive 
investigation should be carried out before the data is conclusive. The role of 
three F-actin regulated proteins was investigated: cofilin, an ubiquitous actin 
binding factor that controls actin polymerisation and reorganisation in 
eukaryotes (DesMarais, et al., 2005, Huang et al., 2006), gelsolin, a major 
actin capping filament (Song et al., 2006) and profilin, an actin monomer 
binding protein linked to dynamic rearrangements of actin cytoskeleton and 
also shown to antagonise the effect of cofilin (Sun et al., 1995, Bottcher, et 
al., 2009)  
 
Multiple signalling pathways have been proposed in mechanisms for 
regulation of cofilin, gelsolin and profilin including Ca2+, cAMP and PI3K 
(Huang et al., 2006, Bottcher, et al., 2009). In addition, profilin and gelsolin 
have been shown to bind phosphatidylinositol 4,5-bisphosphate [PIP2] 
(Burtnick et al., 2004). For the purpose of this study we compared mRNA 
levels of gelsolin, cofilin and profilin and recorded that REV 5901 and 
increased hyperosmolarity showed reduced levels of gelsolin in comparison 
to gadolinium chloride, thus further implication of the role of the SACC in 
regulation of actin dynamics and cell shape regulation. Cofilin gene 
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expression levels were significantly reduced by REV 5901 and a significant 
increase in profilin (cofilin antagonist) was recorded. It is interesting to note 
that profilin levels were significantly increased in cells treated with 
hyperosmotic DMEM but cofilin expression was not significantly different 
compared to cells incubated in control DMEM. Data suggests that volume 
regulation and Ca2+ influx might be related to profilin regulation, with REV 
5901 managing to reduce cofilin via an independent mechanism. Perhaps 
involving another Ca2+ regulated pathway such as protein kinase C (PKC). 
 
To access the influence of REV 5901 on intracellular pathways, proteins 
were extracted and membranes probed, and only gelsolin and cofilin were 
detected. Gelsolin is a major actin capping filament known for capping and 
severing proteins and has been reported to be regulated by PLC activity 
(Song et al., 2006) and was not significantly altered by REV 5901, L-665,238, 
hyperosmotic DMEM and uridine. Cells pre treated with the PI3K inhibitor 
wortmannin or Latrunculin B (an inhibitor of actin polymerisation) exhibited an 
increase in gelsolin, therefore proposing a potential mechanism for why F-
actin levels were decreased, when zone actin cytoskeleton organisation was 
examined.  
 
Cofilin (actin depolymerising protein) levels were significantly reduced by 
addition of REV 5901 by 28 % (data is in reaffirmation of mRNA analysis) 
and significantly increased by addition of Latrunculin B by ~ 3-fold (compared 
to REV 5901 alone) and wortmannin by ~3.2-fold. This data confirms 
previous studies that looked at cofilin in relation to Latrunculin B (Chiu et al., 
2010) and wortmannin, which has previously been shown to activate cofilin 
by a number of stimuli (Bramburg and Bernstein, 2010). Interestingly, levels 
of cofilin were substantially increased in cells treated with L-655,238 (REV 
5901 para-isomer) suggesting a potential reason why the chondro-protective 
effect over time was reduced for cells treated with L-655,238 and why REV 
5901 was the most effect para-isomer when compared together. 
 
Further investigation into the actin cytoskeleton needs to be carried out and 
data for vimentin and tubulin needs to be investigated before a final 
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conclusion can be made, however the current data suggests that REV 5901 
works via PI3K (Figure 5.2). 
 
 
 
 
 
 
 
 
Figure 5.2 Theoretical Model of the mechanism of REV 5901. 
 
In order to investigate the chondro-protective action of REV 5901 shown in this study a 
theoretical model of its mechanism is presented here. REV 5901 is known to increase Ca2+ 
and Ca2+ has been reported as a very important factor in mechanotransduction, volume 
regulation and cell death. By blocking the Ca2+ rise with wortmannin (WMN) a blocker of the 
PI3K pathway and by GdCl3 inhibitor of the SACC the chondro-protection offered by REV 
5901 was inhibited. In addition, this triggered changes in F-actin thus also implicating cell 
cytockeleton is a major factor of interest in chondro-protection. 
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5.5 Conclusions  
 
In conclusion, the results presented here demonstrate the mechanism of 
chondro-protection by hypertonic challenge and REV 5901 and suggest a 
mechanism by which cell shrinkage and the lack of RVI can protect 
chondrocytes from impact trauma.  
 
The regulation of the chondrocyte actin cytoskeleton remains to be 
elucidated, but it would appear to be dependent upon both an increase in 
intracellular calcium and stretch. Future work is required to determine the 
mechanism of the calcium induced actin polymerisation and the regulation of 
cell volume, which when fully elucidated, may offer a potential mechanism to 
protect chondrocytes from impact trauma, as well as offer an insight into the 
progression of OA.  
5.6 Future Work 
 
To enhance these data, future research into the forms and mechanisms of 
cell death involved needs to be applied. Methods including TUNEL assay 
and Annexin V binding for apoptosis and LDH content for necrosis will be 
utilised on post impacted articular cartilage explants to rule out or confirm 
whether apoptotic or necrotic cell death is involved and offer a quantification 
of data. Additional PCR and Western blots will be performed to determine 
changes in expression of cofilin, phospho-cofilin, profilin and gelsolin post 
impact thus furthering the investigation of the mechanism behind cell death. 
 
Having established that the cytoskeleton plays an important role in cell 
biomechanics, further investigation into the live cytoskeletal dynamics 
following impact of in situ chondrocytes and determination of real time 
changes following both osmotic and impact stimuli can be performed. This 
would involve the utilisation of CLSM techniques using a high-speed 4D 
imaging systems and transfection of live cells with key proteins such as actin 
(Figure 5.3), tubulin and vimentin, these would be fluorescently labelled to 
investigate the responses and their remodelling to impact and 
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pharmacological agents in real-time. Once cytoskeleton analysis has been 
carried out, a novel method of analysing the cytoskeleton can be developed 
called ‘Filament Tracer Analysis,’ a feature of Imaris 7.1 software which can 
be used for offering a better understanding of this key element for cell 
survival (Figure 5.4). The outcome of the analysis may aid studies in actin-
dependent signalling pathways, including responses to cytokines, growth 
factors and mechanotransduction pathways.   
  
Subsequently, a human in situ chondrocyte model needs to be developed, 
where by investigation into the real time cytoskeletal dynamics would be 
valuable to integrate physiological, mechanical, and biochemical stimuli. 
Thus helping tissue engineering in the creation of an engineered tissue with 
sufficient extracellular matrix (ECM) composition, geometry, and material 
properties before in vivo implantation. Since tissue growth is complex and 
regulated by numerous factors such as nutrients, mechanical loading and 
growth factors, different bioreactors such as continuous fluid flow (Gemmiti 
and Guldberg, 2006) and concentric cylinders (Wick and Farooque, 2009) 
have been used. Loading cartilage in situ results in the generation of various 
complex stimuli (Chapters 3 & 4) that modulate chondrocytes activities and a 
better understanding of loading of articular cartilage and the effect on 
cytoskeletal dynamic will be inevitable for large scale tissue production 
bioprocess. 
 
Further studies are needed to identify biological and mechanical mechanisms 
related to alterations stimulated by load. Moreover, the expression of proteins 
and genes to loading should be examined on a tissue level response. 
Present studies (Poulet et al., 2011, Ko et al., 2013) have looked into 
development of in vivo mouse models where further investigation of the 
articular cartilage integrity to high impact spots exercise was measured. 
Therefore potential investigation of REV 5901 in these in vivo models could 
provide additional information to the suitability of this compound as a 
chondro-protective agent prior to human based studies. 
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Figure 5.3 Transfected live cells with Red Fluorescent Actin. 
 
Preliminary work on live cell transfected with CellLight® RFP Actin was carried out to 
establish a protocol for future work (A) chondrocyte cell line C-20/A4 and (B) bovine primary 
chondrocytes (Po). Images were acquired with CLSM Leica SP2 and the appropriate TRITC 
filters in a temperature-controlled environment, cells were imaged with x63 immersion 
objective, 4x zoom. Bar = 11.9 µm 
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Figure 5.4 Novel method for cytoskeletal analysis. 
 
To investigate the behaviour of cytoskeleton dynamics a novel method that uses filament 
tracer feature of Imaris 7.1 can be developed where filament traser feature is applied to 
phalloidin labled cells to distinguish F-actin filaments in various conditions. (A) SZ cell in 
control (280 mOsm) DMEM (B) SZ cell in hypertonic (380 mOSm) DMEM (C) DZ cell in 
control (280 mOsm) DMEM and (D) DZ cell in hypertonic (380 mOSM) DMEM. 
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Appendix I Conference Abstracts  
 
The role of the actin cytoskeleton in chondrocyte protection 
following single impact. 
 
Yanitsa Nedelcheva, Stephen Getting, Mark Kerrigan 
 
School of Life Sciences, University of Westminster, London, United Kingdom. 
 
Impact trauma results in cartilage damage and a pre-disposition to 
osteoarthritis, which leads to joint pain, stiffness and ultimately failure. 
Chondrocytes, the sole resident cell-type in cartilage, are responsible for the 
maintenance of the extracellular matrix (ECM) in response to their physico-
chemical environment. As chondrocytes do not divide, it is therefore 
essential to find a method to protect chondrocytes from impact and thus 
maintain chondrocyte viability and cartilage integrity.   
 
Full-depth cartilage was removed from bovine metacarpal-pharengeal joints 
(♀; 18-24months of age) under aseptic conditions. Explants were incubated 
with 5µM calcein-AM and 1µM propidium iodide for 30mins and impact 
experiments performed by drop-tower with a single impact of 0.07, 0.131 & 
0.263J. The effect was studied by confocal laser scanning microscopy 
(CLSM) and quantified using an automated method with Imaris ‘Spots’. The 
effect of cell shrinkage and stretch-sensitive calcium channels were 
determined using hypertonic media (380mOsm) and 100µM GdCl3 
respectively. Actin organisation was measured on Alexa-488 phalloidin 
labelled chondrocytes by CLSM. Cytokines Interleukin-1 Beta (IL-1β), and 
Monocyte Chemoattractant Protein 1 (MCP 1) levels were determined in 
supernatants by commercially available ELISA and nitric oxide (NO) by 
greiss assay. All data are expressed as Mean ± s.e.m. *p<0.05 vs. control, n 
= 4-6 at three determinations.   
 
Data were analysed using Imaris 6.02 ‘Spots’ and following 20mins post 
impact, there was a significant decrease in cell viability  (p<0.05) for both 
higher impact forces when compared toinitial cell death and the lower impact 
force of 0.07J. These data compared to previously published results thus 
validating this technique (Bush et al., 2005). A pre-incubation in hypertonic 
media protected chondrocytes from cell death whereby at 20mins death was 
decreased from 9.22 ± 1.65% to 3.42 ± 0.60 % (p<0.01), inhibited by 100µm 
GdCl3 (20.45 ± 3.88% death at 20mins) thus implicating stretch-sensitive 
calcium channels. The polymerised actin cytoskeleton was labelled using 
Alexa 488-phalldoidin. Hypertonicity increased cortical actin by 29.1 ± 0.13% 
for all zones of cartilage (p<0.01) and was inhibited by 100µm GdCl3. 
Analysis of the supernatants revealed an increase in IL-1β (1.5±0.15pg/g), 
(MCP1 523±126 pg/g), NO (1241±173µg/ml) over the 24hour period post 
impact p<0.05 vs control values. 
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These data show a new method for the analysis of impact-mediated 
chondrocyte viability and that hypertonic chondro-protection is mediated by a 
stretch-sensitive, calcium-dependent polymerisation of the actin 
cytoskeleton. Cartilage impact caused the release of pro-inflammatory 
cytokines that will decrease cartilage viability. Therefore, therapeutic 
modulation of actin polymerisation will protect chondrocytes from impact 
damage and could offer a suitable method to decrease the pre-disposition to 
osteoarthritis.   
 
Bush, P., et al., Osteoarthritis and Cartilage, 2005. 13(1): p. 54-65  
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REV 5901: the protective effect on bovine articular chondrocytes 
following single impact trauma. 
 
Y. Nedelcheva, S. J. Getting, M. J. Kerrigan 
 
School of Life Sciences, University of Westminster, London, United Kingdom. 
 
A single impact load to a diarthrodial joint can cause permanent damage to 
the cartilage extracellular matrix (ECM), including surface fissures, loss of 
proteoglycan, cell death and a subsequent pre-disposition to osteoarthritis 
(Bush et al., 2005, Scott & Athanasiou, 2006). Chondrocytes being the sole 
resident cell-type in cartilage are responsible for the maintenance of the 
ECM therefore, as these cells do not divide it is vital to find a mechanism that 
protects chondrocytes from the effects of impact and thus prolongs their 
viability.  
 
Full-depth cartilage was excised from bovine metacarpal-phalangeal joints 
(18-24 months of age; obtained from the local abattoir) under aseptic 
conditions into DMEM. Explants were incubated with 5µM calcein-AM and 
1µM propidium iodide for 30 min and impact experiments performed by drop-
tower with a single impact of 0.131J. Samples were incubated alone or in the 
presence of REV5901 (50µM, 30mins). Cell viability was determined at 0, 5, 
10, 20 & 30mins post impact by confocal laser scanning microscopy (CLSM) 
and quantified using an automated method with Imaris 7.0 ‘Spots’ as 
previously described (Nedelcheva et al. 2008). Actin organisation was 
measured using Alexa-488 phalloidin labelled chondrocytes by CLSM, whilst 
RT-PCR evaluated alterations in cofilin and profilin mRNA levels. 
Amplification products were visualized by ethidium bromide fluorescence on 
2% agarose gels and changes in expression quantified. All data are 
expressed as Mean ± s.e.m. *P<0.05 vs. control, n = 4 determination in 
triplicate. 
 
Impact led to a decrease in chondrocyte viability of 11.23 ± 1.24% at 30mins, 
this was significantly reduced in chondrocytes pre-treated with REV5901 and 
caused a reduction in cell death by 51% to 5.44%± 0.59% (p<0.001; 
Student’s t-test). REV5901 caused an increase in cortical actin staining by 
20% to 78.72 ±3.99 AU within the superficial zone of articular cartilage 
(P<0.01; Student’s t-test) with no significant alterations observed in the mid 
and deep zones with values of 61.17 ± 4.25 AU and 47.50 ± 2.12 AU 
respectively. When comparing the differences between the mid and deep 
zone no significant difference was observed (P>0.05). RT-PCR of mRNA 
extracted from REV5901 treated chondrocytes indicated alterations in cofilin 
and profilin mRNA compared to untreated chondrocytes. There was no 
significant difference detected in gelsolin mRNA.   
 
These data highlight that REV5901 protects chondrocytes from acute trauma 
due in part to chondro-protective polymerisation of the actin cytoskeleton. 
Therapeutic modulation of the actin modulation and the pathway that 
REV5901 is involved in could offer novel therapeutic opportunities for 
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prevention of irreversible cartilage damage from acute impact trauma and 
minimize pre-disposition to osteoarthritis. 
 
Bush, P., et al., (2005). Viability and volume of in situ bovine articular 
chondrocytes—changes following a single impact and effects of medium osmolarity. 
Osteoarthritis Cartilage, 13(1), 54-65 
 
Nedelcheva, Y., et al., (2008). The role of the actin cytoskeleton in chondrocyte 
protection following single impact. E-journal of the British Pharmacological Society. 
148P 
 
Scott, C., Athanasiou, K., (2006). Mechanical impact and articular cartilage. Critical 
reviews in biomedical engineering. 34(5), 347-378 
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REV5901: an investigation on the chondroprotective 
effect in bovine chondrocytes following single impact 
trauma. 
Y. Nedelcheva, S. J. Getting, M. J. Kerrigan 
 
School of Life Sciences, University of Westminster, London, United Kingdom. 
 
Chondrocytes, the sole resident cell-type in cartilage are responsible for the 
maintenance of the extracellular matrix and as they do not divide it is vital to 
find a protective mechanism against impact trauma. A single impact load to a 
joint causes subchondral bone fracture resulting in permanent cartilage 
damage to the ECM, including surface fissures, loss of proteoglycan, cell 
death and pre-disposition to osteoarthritis (Bush et al., 2005, Scott & 
Athanasiou, 2006). 
  
Full-depth cartilage was excised from bovine metacarpal-phalangeal joints 
(18-24 months of age, obtained with permission from a local abattoir) under 
aseptic conditions. Explants were incubated with 5µM calcein-AM and 1µM 
propidium iodide for 30 min and impact experiments were performed by 
drop-tower with a single impact of 0.131J. Samples were incubated alone or 
in the presence of REV 5901 (50 µM, 30 min). To determine the mechanism 
of REV 5901 we used Wortmannin (10nM) and Uridine (100µM). Cell viability 
was determined time points of 0, 5, 10, 20 & 30 mins post impact by confocal 
laser scanning microscopy (CLSM) and quantified using an automated 
method with Imaris ‘Spots’. Data for cell volume was determined in non-
impacted samples and 30 min post impact. Western blot analysis were used 
to determine alterations in actin binding proteins: cofilin, gelsolin, profilin, and 
phospho cofilin to. Protein bands were analysed by Image J software and 
changes in expression quantified. All data are expressed as Mean ± s.e.m. 
*P<0.05 vs. control, n = 4 determination in triplicate. 
 
Impact led to cell death which was significantly reduced by a pre-incubation  
with REV 5901 from 10.92±1.02% to 5.44%±0.59% (p<0.001). Samples 
treated with Uridine caused a reduction of cell death that was significantly 
lower from the control samples 8.10±0.40% (p<0.05) but couldn’t reach the 
chondro-protective effect offered by REV 5901 (p<0.01). In contrast, samples 
treated with Wortmannin increased cell death to 12.02±1.83%. Interestingly, 
cell death was significantly reduced in samples treated in combination with 
Wortmanin and REV 5901 8.58±0.54%. Data for volume changes showed 
significant decrease in volume for cell treated with Wortmannin 
359.9±17.67µm3, compared to 716.136±37.81µm3 and 552.68±27.26 µm3 for 
control (p<0.001) and REV 5901 (p<0.001) respectively. Nevertheless, cell 
volume for cells treated with Uridine significantly decreased in comparison to 
the control 608.3±24.32µm3 (p<0.05). In addition, when cells were treated 
with a combination of Wortmannin and REV5901 cell volume size was 
restored to 538.09±30.6µm3. Western blot analysis showed that only cofilin 
and gelsolin from the actin binding proteins were expressed in all the 
samples, no profilin or phospho-cofilin were detected. 
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These data confirm the therapeutic opportunities offered by REV 5901 and 
it’s chondro-protective properties in part due to the polymerisation of the 
actin cytoskeleton. We suggest that the pathway that is involved is via the 
phosphoinositide 3-kinases (PI3Ks) and could offer novel therapeutic 
opportunities for prevention of irreversible cartilage damage from acute 
impact trauma. 
 
Bush, P, et al., (2005). Viability and volume of in situ bovine articular 
chondrocytes—changes following a single impact and effects of medium 
osmolarity. Osteoarthritis Cartilage, 13(1), 54-65 
 
Scott, C, Athanasiou, K (2006). Mechanical impact and articular cartilage. 
Critical reviews in biomedical engineering. 34(5), 347-378 
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Appendix III - Buffers  
 
TBST Buffer  
 
1. 10 ml 1M Tris-HCl pH 8.0 
2. 30 ml 5M NaCl 
3. 500 µl Tween-20 
4. ddH2O up to 1 l 
 
Hot Lysis Buffer  
 
1. 0.5 M NaCl 
2. 5 mM EDTA 
3. 1% Triton X100 
4. 10 mM Tris-HCl pH 7.4 
5. 5 M DTT 
 
 
